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ABSTRACT 
 There is consistent evidence demonstrating a “U-shaped” association between 
sleep duration and mortality, as well as several morbidities, such as increased systemic 
inflammation, decreased cognitive performance, and mood disturbances.  Much of the 
information on long sleep is epidemiological in nature.  The present study examined the 
associations between sleep duration and extension on mood, inflammation, and cognition.  
Ten (50-79 y) healthy adults who report sleeping 6-8 h were assessed on cognitive, 
emotional, and inflammatory measures in a cross-over design.  Following a baseline 
week, participants were randomized to one of two three-week treatments: (1) a control 
treatment of habitual time in bed; and (2) a sleep extension treatment, in which 
participants extended their time in bed 2 hours longer than their median baseline time in 
bed.  After 1 week of recovery, participants repeated the 1-week baseline and crossed 
over to the other treatment.  Cognitive function was assessed after the first baseline and 
after each treatment.  Sleepiness, fatigue, depression, anxiety, blood pressure, and heart 
rate were assessed weekly.  Inflammation, glucose, and cholesterol were assessed 
following both treatments.  As expected, sleep disturbance was associated with increased 
blood pressure and heart rate and negative changes in mood.  Unexpectedly, more total 
sleep time was associated with improved blood pressure and heart rate.  Total sleep time 
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and sleep disturbance was not associated with cognition, or clinician-administered mood 
assessments.  The results of the study have important public health relevance, as it 
provides more insight on the associations of sleep duration on physiological health.
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CHAPTER 1 
INTRODUCTION 
Sleep Extension and Stable Sleep Schedules in Older Adults 
Popular opinion reflects the notion that much of society is chronically sleep 
deprived and should sleep as long as possible when given the chance.  Epidemiological 
studies have clearly shown negative associations with extreme sleep duration, and many 
experimental studies have shown negative effects of sleep restriction.  However, it has 
become apparent that sleeping longer is much more hazardous than previously thought, 
and is associated with increased risk of mortality.  Longer sleep duration is also related to 
several morbidities, negatively affecting individuals both physiologically and 
psychologically.  The current study will examine the impact of increased sleep duration 
on depression, inflammation, and cognitive performance in healthy, older adults.   
1.1 ASSOCIATION OF SLEEP DURATION WITH MORTALITY AND 
MORBIDITY 
More than 50 epidemiologic studies over a span of 50 years have consistently 
shown a “U-shaped” relationship between sleep duration and mortality.  The associations 
have demonstrated progressively increased mortality associated with short sleep (≤ 6 
hours; hr) and long sleep (≥ 8 hr), with approximately 7 hours of sleep per night being the 
optimal sleep duration for survival (Amagai et al., 2004; Hublin, Partinen, Koskenvuo, & 
Kaprio, 2007; Kripke, Garfinkel, Wingard, Klauber, & Marler, 2002; Lan, Lan, Wen, 
Lin, & Chuang, 2007; Patel et al., 2004; Tamakoshi & Ohno, 2004).  Additionally, Ferrie 
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et al., (2007) found that changes in sleep duration, as in, decreased sleep and increased 
sleep durations, were associated with increased mortality risk.  Some studies have found 
an increased risk of mortality with just long sleep duration, but not short sleep duration 
(Cohen-Mansfield & Perach, 2012).   
Several meta-analyses have found increased all-cause mortality in both short and 
long sleepers (Cappuccio, D’Elia, Strazzullo, & Miller, 2010; Gallicchio & Kalesan, 
2009).  The relationship between sleep duration and mortality has been demonstrated in 
studies of millions of participants and in several different countries, with follow-up 
testing as long as 10-20 years.  Additionally, these studies have statistically controlled for 
over 30 potential covariates, such as age, sex, obesity, depression, smoking, and 
cardiovascular health.  It appears that older adults may be more vulnerable to the sleep 
duration extremes (Youngstedt & Kripke, 2004). 
Similar U-shaped associations have been found between sleep duration and 
several morbidities, such as depression (Tamakoshi & Ohno, 2004), cardiovascular 
disease (Ayas, White, Manson, et al., 2003), diabetes (Ayas, White, Al-Delaimy, et al., 
2003), stroke (Qureshi, Giles, Croft, & Bliwise, 1997), obesity (Taheri, Lin, Austin, 
Young, & Mignot, 2004), poor lipid profile (Kaneita, Uchiyama, Yoshiike, & Ohida, 
2008; Williams, Hu, Patel, & Mantzoros, 2007), impaired cognitive function (Ferrie et 
al., 2011; Kronholm et al., 2009; Schmutte et al., 2007; Xu et al., 2011), and 
inflammation (Dowd, Goldman, & Weinstein, 2011; Grandner et al., 2013; Patel et al., 
2009; Williams et al., 2007).  Some studies have shown associations between morbidities, 
such as cardiovascular disease, in short sleepers, but not long sleepers (Hoevenaar-Blom, 
Spijkerman, Kromhout, van den Berg, & Verschuren, 2011).  Much of the evidence for 
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the associations between sleep duration and mortality, as well as morbidities, is 
epidemiological in nature.  Therefore, randomized controlled trials are needed to shed 
more light on the impact of sleep duration, or more specifically, long sleep duration.  
Youngstedt and Kripke's (2004) interpretation of Minino and Smith's (2001) Center for 
Disease Control (CDC) 2000 National Vital Statistics Report was that long sleep would 
be the fourth leading cause of death in the United States if it were truly the cause of the 
associated mortality.  As a result, long sleep could be a greater risk to mortality than 
diabetes (Youngstedt & Kripke, 2004). 
1.2 LONG SLEEP: A NEGLECTED RISK FACTOR 
Considering the growing epidemiological evidence, the risks associated with long 
sleep may be as great as, if not greater, than the risks of short sleep (Youngstedt & 
Kripke, 2004).  Some studies have found that a greater proportion of adults report 
sleeping 8 hours or greater per night, as compared to adults reporting sleeping 6 hours or 
less.  This trend suggests that long sleep, or long time in bed (TIB), might be a greater 
societal risk than short sleep (Kripke et al., 2002).  The potential risks related to long 
sleep, or long time in bed, have largely been ignored, in contrast to the vast literature on 
the risks of short sleep, sleep loss, and sleep debt (Balkin & Badia, 1988; Cohen, Doyle, 
Alper, Janicki-Deverts, & Turner, 2009; Karine Spiegel, Leproult, & Van Cauter, 1999; 
Van Dongen, Maislin, Mullington, & Dinges, 2003).  Banks and Dinges (2007) 
completed a review on recent studies of sleep restriction; they noted that the experimental 
studies that restricted sleep found significant negative health effects on metabolic and 
endocrine functions, as well as increased inflammatory responses. 
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A few arguments drive the skepticism that long sleep could be harmful.  First, 
there is debate whether we are actually a sleep deprived society; it is a popular belief that 
a longer sleep duration is healthy and normal.  Second, when asked to report total sleep 
time (TST), individuals tend to erroneously report the time they spent in bed instead of 
time physically sleeping (Hublin et al., 2007).  Additionally, there is always a risk of bias 
in self-reported measures, as individuals may be influenced by societal demands when 
responding to survey questions about sleep (Bliwise & Young, 2007).  Third, there must 
be some underlying confounding mechanism that explains the relationship between long 
sleep and mortality and morbidity (Qureshi et al., 1997).  Finally, many sleep researchers 
debate the association between long sleep and mortality and morbidity by arguing that no 
plausible mechanisms have been found to explain how long sleep could be hazardous 
(Foley, 2004; Knutson & Turek, 2006; Stamatakis & Punjabi, 2007).  Interestingly, Foley 
(2004) expresses the need for randomized controlled trials in order to further research the 
potential mechanisms to explain the association between long sleep and mortality and 
morbidity.  Foley (2004), Knutson and Turek (2006), and Stamatakis and Punjabi (2007) 
all acknowledge that epidemiological evidence is not causal and can only provide limited 
information.  Each of these arguments will be further discussed in more detail. 
1.3 ARE WE A SLEEP DEPRIVED SOCIETY? 
According to the  National Institutes of Health's Commission on Sleep Disorders 
Research (1993), modern industrialized societies are dangerously sleep-deprived.  Some 
evidence suggests that average sleep duration has decreased since industrialization, 
possibly due to artificial light (Ekirch, 2001; Webb & Agnew, 1975), time restraints, and 
choosing to do other activities instead of sleep (L. Hale, 2005; Webb & Agnew, 1975).  
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Bliwise (1996) also reported that fatigue and tiredness has increased in the past few 
decades, and argued that Americans do not consider sleep to be important, and therefore 
do not prioritize it.  Other population trends have paralleled the proposed decrease in 
sleep duration, such as increased diabetes (Spiegel, Knutson, Leproult, Tasali, & Van 
Cauter, 2005) and increased obesity (James, 2008).  Increased expenditure of energy or 
increased stress may explain some of these trends (Taheri et al., 2004).  However, there is 
conflicting evidence to suggest that, in the past 30 years, there has not been a decrease in 
sleep duration, or at least not a rise in individuals reporting less than 6 hours of sleep per 
night (Knutson, Van Cauter, Rathouz, DeLeire, & Lauderdale, 2010; Rowshan Ravan, 
Bengtsson, Lissner, Lapidus, & Björkelund, 2010).  For example, Bin, Marshall, & 
Glozier (2012) recently completed a systematic review, examining self-reported sleep 
duration from the 1960s to 2000s.  They concluded that there has been no consistent 
decrease in sleep duration across 15 countries in the 40-year span (Bin et al., 2012).  
Indeed, for many countries, there was an increase in sleep. 
When not given time restraints, individuals tend to increase their sleep on 
weekends or in experimental laboratory settings (Webb & Agnew, 1975).  However, this 
behavior may be an individual taking advantage of the situation, instead of signifying an 
attempt to rectify sleep debt.  For example, extending sleep when given the option may 
be more similar to overeating on occasion.  Individuals who report that they are less 
likely to sleep longer to replace sleep and are more likely to extend sleep due to pleasure 
or boredom and idleness (Palmer & Harrison, 1983).  There is no consistent evidence that 
shows that sleeping 8 hours or more per night leads to better health, sleep, mood, quality 
of life, or even fewer accidents.  Instead, impairments in mood, health, sleep, and quality 
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of life are reported in individuals who sleep more than 8 hours per night (D. E. Ford & 
Kamerow, 1989; Hartmann, Baekeland, & Zwilling, 1972). 
1.4 LONG TOTAL SLEEP TIME OR LONG TIME IN BED? 
When comparing self-reported sleep time to objective data, such as actigraphy, it 
appears that the total sleep time reported by older adults may actually be more indicative 
of time in bed (Kline et al., 2010).  Kline et al. (2010) also report that, compared to 
objective data, self-reported long sleepers tend to overestimate their total sleep time by 
about 60 minutes.  This overestimation is also found in average sleepers (Diane S. 
Lauderdale, Knutson, Yan, Liu, & Rathouz, 2008; Silva et al., 2007).  Time in bed is 
more modifiable than altering total sleep time; spending less time in bed (i.e. restricting 
sleep) may potentially decrease the risk of mortality and morbidity (Youngstedt & 
Kripke, 2004). 
Time in bed and total sleep time are highly correlated, and it is probable that 
individuals who report sleeping longer in epidemiological studies truly are sleeping 
longer.  Patel, Blackwell, Ancoli-Israel, and Stone (2012) found that self-reported long 
sleepers not only spend more time in bed, but do indeed sleep longer objectively than 
self-reported average sleepers, as confirmed by both actigraphy and polysomnography 
(PSG).  As mentioned previously, there are significant risks associated with objectively 
longer sleep (Kripke, Langer, Elliott, Klauber, & Rex, 2011; van den Berg et al., 2008), 
and associations of increased risk of mortality have been found in studies that 
discriminated between time in bed and total sleep time (Gale & Martyn, 1998; Kojima et 
al., 2000; Kripke et al., 2011).  Much of the epidemiological evidence is based on self-
reports, but corroborating self-reports through the use of objective measurement, such as 
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actigraphy, would increase the validity and integrity of the data and can provide more 
valid and reliable information on the hazardous effects of long sleep. 
1.5 ALTERNATIVE EXPLANATIONS FOR MORTALITY/MORBIDITY 
ASSOCIATION WITH LONG SLEEP  
The associations of long sleep with mortality and morbidity found in 
epidemiological studies might be explained by multiple psychobiological and 
sociobehavioral factors.  These  factors include sleep fragmentation (Lan et al., 2007; 
Youngstedt & Kripke, 2004), poor sleep quality (Lan et al., 2007), sleep apnea (Bliwise, 
King, & Harris, 1994; Qureshi et al., 1997), daytime sleepiness (Bliwise et al., 1994), 
depression (Patel, Malhotra, Gottlieb, White, & Hu, 2006), low socioeconomic status 
([SES]; (Hale, 2005; Lauderdale, 2006; Patel et al., 2006), unemployment (Kronholm, 
Härmä, Hublin, Aro, & Partonen, 2006), race (Lauren Hale & Do, 2007; Lauderdale, 
2006), and low physical activity (Hublin et al., 2007; Morgan, 2007; Taheri et al., 2004).  
Many of the factors are also associated with significant health problems; long sleep could 
indicate declining health (Youngstedt & Kripke, 2004).   
Epidemiological studies attempt to statistically control for factors that are 
believed to influence the relationship between long sleep and mortality and morbidity.  It 
can be argued that perhaps not all the factors are controlled for sufficiently.  Additionally, 
the interactions between correlated variables may not be statistically examined in an 
efficient manner.  One major concern for control of some of the factors in 
epidemiological studies is how specifically it may impact long sleep.  For example, if 
long sleepers tend to be less physically active (Hublin et al., 2007; Morgan, 2007; Taheri 
et al., 2004), then controlling for exercise could underestimate the effects of long sleep on 
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mortality.  In order to provide more evidence on how long sleep may be hazardous, 
randomized controlled trials are needed.  Additionally, randomized controlled trials help 
solve the issue of difficult to control confounding factors found in epidemiological 
research and would provide more evidence on the potential hazardous nature of long 
sleep. 
1.6 EXPERIMENTAL STUDY OF SLEEP EXTENSION  
Sleep extension has not been studied rigorously in the sleep field.  A few studies 
were completed in the late 1960’s and early 1970’s that examined sleep extension in 
healthy young men (Globus, 1969; J. M. Taub & Berger, 1969; Taub & Berger, 1973).  In 
a recent study of young adults, we asked participants to increase their sleep by 3 hours 
per night for one week (Reynolds, Bowles, Saxena, Fayad, & Youngstedt, 2014).  
Although limited by a small sample size, we found increased symptoms of depression 
and anxiety, as well as increased systemic inflammatory markers in individuals who 
extended sleep, compared to those who maintained their normal sleep patterns.  To date, 
the Reynolds et al. (2014) study is the most comprehensive randomized controlled study 
that has examined the effects of sleep extension. 
The current trend is to use sleep extension as an intervention for individuals who 
are habitually sleep deprived in order to improve specific health conditions, such as blood 
pressure (Haack, Serrador, & Cohen, 2013), obesity (Cizza et al., 2010), fasting insulin 
sensitivity (Leproult, Deliens, Gilson, & Peigneux, 2014), cognitive performance 
(Lucassen et al., 2014), and food desirability (Tasali, Chapotot, Wroblewski, & Schoeller, 
2014). However, no studies to date have been published examining the effects of sleep 
extension in habitually normal sleeping older adults.  In order to fully understand the 
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impact of longer sleep, it is important to complete randomized controlled trials.  
Additionally, it is important to examine sleep extension in different age groups, as the 
effects of extended sleep may impact age groups differently. 
1.7 HOW MIGHT LONG SLEEP BE HAZARDOUS?  
It can be posited that excessive amounts of all healthful behaviors, such as 
exercise, caloric intake, and exposure to sunlight, could be hazardous.  Several 
mechanisms explain how long sleep, or spending more time in bed, could be hazardous 
(Youngstedt & Kripke, 2004).  Physically spending more time in bed could be harmful to 
health, as significant impairments in insulin insensitivity and cardiovascular function 
have resulted from just minimal bed-rest of 2 (Schneider et al., 2009) to 5 (Hamburg et 
al., 2007) days of bed-rest.  Additionally, long sleep has been associated with lower 
levels of daytime physical activity and more sedentary behavior (Hublin et al., 2007).   
Long sleep is correlated with increased sleep fragmentation; poor health outcomes 
have also been associated with sleep fragmentation in experimental studies (Horner, 
1996; Stepanski, 2002).  There is also an association between lipid levels and long sleep, 
with long sleep potentially leading to abnormal cholesterol levels, or dyslipidemia 
(Kaneita et al., 2008; van den Berg et al., 2008).  Another mechanism by which long 
sleep is harmful is that extended time in bed is correlated with decreased light exposure, 
and light exposure is highly related to depression (Bhattacharjee, 2007).  Additionally, 
individuals who sleep longer are exposed to a shorter photoperiod, or day-length, and 
decreased exposure to light could disrupt the circadian pacemaker and perpetuate long 
sleep duration (Aeschbach et al., 2003).  An altered photoperiod has been associated with 
mortality in several species (Gordon, 1998).  Lethargy and grogginess are commonly 
10 
reported by long sleepers and excessive sleeping (Globus, 1969; Hartmann et al., 1972; J. 
M. Taub & Berger, 1969; John M. Taub & Berger, 1973) and may actually indicate 
underlying depression, cognitive impairment, and/or cytokine imbalance caused by 
excessive sleeping. 
1.8 LONG SLEEP AND INDIVIDUAL MECHANISMS  
1.8.1 Long sleep and inactivity. Long sleep has been associated with sedentary 
behavior and low levels of daytime physical activity (Hublin et al., 2007).  This 
association could be explained by long sleepers making less time for physical activity and 
instead opting for more sedentary behaviors, such as watching television (Basner et al., 
2007).  The association between long sleep and lower daytime physical activity levels 
could also be explained by feelings of lethargy commonly reported by long sleepers and 
excessive sleeping (Globus, 1969; Hartmann et al., 1972; J. M. Taub & Berger, 1969; 
John M. Taub & Berger, 1973).   
Only one extra hour per day of sedentary behavior, such as watching television or 
using a computer, has been associated with adverse health effects, such as metabolic 
syndrome (Ford, Kohl, Mokdad, & Ajani, 2005).  Bed-rest studies have shown significant 
impairments in insulin sensitivity and cardiovascular function after just 2 days (Schneider 
et al., 2009) and 5 days of bed rest (Hamburg et al., 2007).  More prolonged bed-rest 
elicits profound deficits in bone density, muscle function, systemic inflammation, and 
insulin resistance (Brower, 2009), as well as mood disturbances (Ishizaki et al., 2002).  
Associations have been made between lipid levels and long sleep, with long sleep 
potentially leading to abnormal cholesterol levels, or dyslipidemia (Kaneita, Uchiyama, 
Yoshiike, & Ohida, 2008; van den Berg et al., 2008).   
11 
1.8.2 Long sleep and sleep fragmentation. Long sleep is associated with 
increased sleep fragmentation (Youngstedt & Kripke, 2004).  Additionally, long sleepers 
tend to report more body aches and pains compared to shorter sleepers (Hartmann et al., 
1972), which suggests that long sleepers experience more pain due to sleep disruption.  
Increased sleep fragmentation has been associated with poor health outcomes in 
experimentally induced sleep fragmentation (Horner, 1996; Stepanski, 2002), as well as 
epidemiologic research (Bennett, Barbour, Langford, Stradling, & Davies, 1999).  For 
example, increased sleep fragmentation is associated with degraded mood and decreased 
cognitive performance (Bonnet, 1985, 1986; Stepanski, 2002).  Furthermore, van den 
Berg et al. (2008) found an association between unhealthy cholesterol levels and long 
sleep, and posited that sleep fragmentation and longer time in bed explain this association 
in older adults.  Disrupted sleep may even play a part in predicting mortality (Dew et al., 
2003).  
Sleep fragmentation is usually defined as arousal during sleep that results in 
increased electroencephalography (EEG) frequency of at least 3 seconds, as an increase 
even at this level is correlated with significantly increased daytime sleepiness.  Other 
definitions also include an electromyography (EMG) amplitude increase (Stepanski, 
2002).  The Sleep Continuity Theory attempts to explain how fragmented sleep impacts 
daytime function.  In order for sleep to be restorative, an individual must sleep 
consecutively (uninterrupted) for a minimum of 10 minutes (Bonnet, 1985, 1986).  
Carskadon, Brown, and Dement (1982) found that older adults tend to have substantially 
more fragmented sleep, and the decreased continuity of sleep was highly correlated with 
daytime well-being. 
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The effects of sleep fragmentation mimic those of sleep deprivation (Stepanski, 
2002).  In fact, it is argued that sleep fragmentation actually results in partial sleep 
deprivation, which leads to increased daytime sleepiness.  Sleep debt may be accrued as 
stage one sleep is increased in combination with decreased total sleep time.  This 
argument is also fueled by the notion that stage one sleep may not be as restorative as 
other stages of sleep (Stepanski, 2002).  As a further explanation, even though an 
individual may spend more time in bed and have a greater total number of hours of sleep, 
sleep fragmentation results in decreased consecutive minutes of sleep.  The decrease of 
depth and continuous waking essentially leads to sleep loss, as well as symptoms that are 
commonly associated with sleep deprivation. 
Impairments in cognitive performance are found in studies of disrupted sleep 
(Bonnet, 1985, 1986).  A few hypotheses attempt to explain the relationship between long 
sleep and cognitive performance.  Fatigue and tiredness, which are reported in sleep 
extension, (Taub & Berger, 1969; Taub & Berger, 1973) long sleepers (Hartmann et al., 
1972), and excessive sleeping (Globus, 1969), may indicate that spending more time in 
bed is not beneficial.  Poor sleep quality is also believed to be the culprit that leads to 
impaired cognitive performance (Xu et al., 2011).  Another hypothesis attempting to 
explain impaired cognitive performance is that prolonged elevation of plasma melatonin 
levels in the daytime (Aeschbach et al., 2003) could inhibit memory formation 
(Kronholm et al., 2009; Rawashdeh, de Borsetti, Roman, & Cahill, 2007).   
Dew et al. (2003) found that specific sleep parameters predicted the probability of 
mortality in older adults.  They argued that a plausible explanation is that disrupted sleep 
could indicate dysfunction in brain regions associated with thalamocortical circuits, 
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which are responsible for maintaining sleep.  Additionally, evidence may suggest that 
changes in the immune system are modulated by sleep disturbances (Dew et al., 2003).   
1.8.3 Long sleep and inflammation. Recent evidence has shown that 
inflammation may serve as a mediator of the association of long sleep with mortality 
(Penninx, Milaneschi, Lamers, & Vogelzangs, 2013).  Several studies have shown an 
association between long sleep duration and increased levels of inflammation (Dowd et 
al., 2011; Grandner et al., 2013; Patel et al., 2009; Williams et al., 2007).  Longer sleep 
duration may affect cytokines that are important for regulating inflammation.  Increased 
levels of proteins and cytokines, such as C-reactive protein (CRP) and interleukin-6 (IL-
6), are associated with an increased risk of diseases such as diabetes and cardiovascular 
disease.  Since sleep duration may be involved in the regulation of these cytokines, these 
associations may potentially have a significant impact on long-term health (Patel et al., 
2009).  Moreover, increased levels of IL-6 and CRP in older adults have been correlated 
with increased risk of mortality (Harris et al., 1999).  It is important to understand the 
physiology of inflammation and how sleep may affect these processes, especially in older 
adults.   
Elevated systemic inflammation is a response to infection and/or tissue damage; 
elevations in proteins and cytokines such as CRP and IL-6, respectively, without 
infection or tissue damage are considered abnormal and increase the risk of developing 
diseases such as cardiovascular disease and diabetes.  A dysregulated inflammatory 
response may result from the activation of the immune system in this abnormal 
circumstance.  In response to a perceived threat, pro-inflammatory cytokines (such as IL-
6 and tumor necrosis factor [TNF]-α) are produced.  Anti-inflammatory cytokines are 
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called into action to reduce pro-inflammatory cytokines by attenuating production or 
working at the receptor level.  Then, acute phase proteins (such as CRP) are synthesized, 
leading to the systemic inflammatory response (Penninx et al., 2013). 
The direction of the relationship between long sleep duration and increased 
inflammation is not clearly understood.  It is important to recognize that understanding 
the causal nature of the relationship relies on experimental study to determine whether 
increased inflammation causes or is caused by long sleep duration.  Long sleep may 
directly cause increased inflammation in that cytokine expression may be impacted by the 
more frequent awakenings and increased sleep fragmentation (Dowd et al., 2011).  
However, it is also posited that cytokines may have a direct effect on the brain and 
predispose an individual to longer sleep durations, since cytokines, such as IL-6, tend to 
induce sleep.  Additionally, an increase in sleep duration may correspond with declining 
health and the aging process in individuals over 60 (Dowd et al., 2011). 
Dowd et al. (2011) recently conducted a study examining self-reported sleep 
duration and levels of inflammatory biomarkers and found that higher levels of IL-6 were 
associated with longer sleepers in the Taiwanese population.  There was no significant 
relationship between short sleep and higher inflammation levels.  Since this was a 
prospective study, it was concluded that the relationship between long sleep and 
increased inflammation was not due to acute illness, but to physiological processes that 
are expressed in a longer time period (Dowd et al., 2011).  In a recent study, researchers 
also found an association between long sleepers and increased levels of CRP, as well as 
no association between short sleep duration and CRP after adjusting for medical and 
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sleep comorbidities (Grandner et al., 2013).  Higher levels of both CRP and IL-6 have 
been found in long sleepers (Patel et al., 2009). 
Conversely, Matthews et al. (2010) found that shorter sleep durations, as 
measured by PSG, were associated with higher levels of CRP in African Americans and 
higher plasminogen activator inhibitor (PAI-1) in Chinese individuals.  Unfortunately, the 
authors did not examine the relationship between longer sleep duration and biomarkers of 
inflammation due to the small sample of individuals who reported sleeping greater than 8 
hours per night.  However, they found interesting relationships between other sleep 
characteristics and biomarkers of inflammation: in initial models, sleep disordered 
breathing, sleep continuity, and quality were associated with coagulation and levels of 
inflammation (Matthews et al., 2010). 
Increased levels of TNF-α and IL-6 are reported in individuals with disorders who 
exhibit excessive daytime sleepiness (Papanicolaou, Wilder, Manolagas, & Chrousos, 
1998; Vgontzas et al., 1997), such as individuals with sleep apnea (Vgontzas et al., 1997).  
Individuals with sleep disordered breathing, like sleep apnea, may spend more time in 
bed in order to make up for fragmented sleep (Taheri et al., 2004).  Moreover, lethargy 
and grogginess, as reported in sleep extension (Taub & Berger, 1969; Taub & Berger, 
1973), long sleepers (Hartmann et al., 1972), and excessive sleeping (Globus, 1969), may 
indicate cytokine imbalance (Papanicolaou et al., 1998; Vgontzas et al., 1997).  Evening 
levels of inflammatory biomarkers in addition to slow wave sleep have been shown to 
predict fatigue (Thomas, Motivala, Olmstead, & Irwin, 2011).  Long time in bed may 
lead to increased sleep fragmentation and decreased sleep depth (Youngstedt & Kripke, 
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2004).  Furthermore, decreased sleep depth, as in less slow wave sleep, is correlated with 
both daytime fatigue and increased inflammation (Thomas et al., 2011). 
There is clear evidence that inflammation has strong correlations with sleep depth, 
sleep quality, and sleep duration, as well as physiological symptoms such as fatigue.  
Additionally, increased levels of inflammation have been associated with cognitive 
decline (Gimeno, Marmot, & Singh-Manoux, 2008; Weaver et al., 2002).  Inflammation 
has also been associated with other morbidities, such as mood disorders.  Recent 
evidence has shown correlations between inflammation and anxiety (Vogelzangs, 
Beekman, de Jonge, & Penninx, 2013), as well as depression (Penninx et al., 2013).   
1.8.4 Long sleep and mood/emotion. Depression and sleep disturbances have 
high rates of co-occurrence (Tsuno, Besset, & Ritchie, 2005), and depression is 
associated with long sleep duration (Breslau, Roth, Rosenthal, & Andreski, 1996; Ferrie 
et al., 2011; Ford & Kamerow, 1989; Hartmann et al., 1972; Tsuno et al., 2005).  In their 
meta-analysis on sleep and depression, Tsuno et al. (2005) discussed some of the most 
common alterations in sleep architecture found in individuals with depression, including 
impaired sleep efficiency and decreased sleep depth.  Additionally, individuals with 
depression were more likely to have higher levels of  rapid-eye movement (REM) sleep, 
such as shortened REM sleep latency and increased density of eye movements during 
REM sleep (Tsuno et al., 2005). 
The relationship between sleep and psychiatric disorders, such as depression and 
anxiety, is complex.  The direction of this relationship is not well understood, however, 
we do have correlational evidence of the relationship between sleep and mood disorders.  
Studies have consistently shown that sleep disturbances predict major depressive 
17 
episodes (Breslau et al., 1996; Tsuno et al., 2005).  Gillespie et al. (2012) conducted a 
twin study and examined the relationship between measures of self-reported disrupted 
sleep and symptoms of depression and anxiety.  They found an interesting age-difference 
trend: the relationship between disrupted sleep and anxiety and depression was reciprocal 
in older women, whereas, in younger women, anxiety and depression were associated 
with disrupted sleep.  The relationship in men was not as clear (Gillespie et al., 2012).    
The combination of sleep abnormalities, such as shortened REM sleep latency and 
reduced slow wave sleep, may be more strongly associated with mood disorders (Tsuno 
et al., 2005).  Interestingly, Ford and Kamerow (1989) found that individuals who 
reported hypersomnia of longer durations had a higher chance of reporting major 
depression than those who experienced a recent episode of hypersomnia.  Moreover, 
individuals whose hypersomnia was alleviated still had a higher risk of reporting 
depression (Ford & Kamerow, 1989). 
As mentioned earlier, lethargy and grogginess are reported following sleep 
extension, (Taub & Berger, 1969; Taub & Berger, 1973) in long sleepers (Hartmann et 
al., 1972), and following excessive sleeping (Globus, 1969), and may contribute to 
depression.  Light exposure may be another mechanism by which sleep and depression 
are related.  Less exposure to light is associated with depressed mood (Bhattacharjee, 
2007).  Individuals who sleep longer are exposed to a shorter photoperiod, and this 
decreased exposure to light could disrupt the circadian pacemaker and perpetuate long 
sleep duration (Aeschbach et al., 2003).   
Moreover, an altered photoperiod has been associated with mortality in several 
species (Gordon, 1998).  Individuals with seasonal affective disorder (SAD) are more 
18 
likely than other subtypes of depression to report hypersomnia.  Additionally, there is 
evidence that supports the hypothesis that individuals with SAD have circadian phase 
delay, as exposure to bright light in the morning is used as a treatment to cause phase 
advance (Bhattacharjee, 2007; Tsuno et al., 2005).  Furthermore, Bhattacharjee (2007) 
argued that some forms of depression may be a result of a depressed individual’s out of 
sync circadian clock with the sleep-wake cycle.  Depressive symptoms may lead to 
impairments in cognition, as associations between cognitive decline and depression in 
older adults have been well-established (Bielak, Gerstorf, Kiely, Anstey, & Luszcz, 
2011).   
1.8.5 Long sleep and cognitive impairment. Recent epidemiological studies 
show an interesting relationship between sleep duration and cognitive functioning.  More 
specifically, many of the recent studies examined the impact of short and long sleep 
durations on fluid intelligence.  Fluid intelligence is described as the ability to reason and 
think abstractly in new situations and environments, and is related to performance in 
higher-order cognitive tasks (Heitz, Unsworth, & Engle, 2005).  Working memory tasks 
demonstrate an individual’s ability to control attention, which is a construct of fluid 
intelligence.  The executive control is also considered a construct of attention and related 
to fluid intelligence (Heitz et al., 2005).  Inhibition (including interference control and 
selective attention), working memory, and cognitive flexibility make up the three core 
executive functions (Diamond, 2013). 
Poor quality of sleep may derange metabolic and endocrine function, which in 
turn would result in cognitive dysfunction (Jelicic et al., 2002; Spiegel et al., 1999).  
Nebes, Buysse, Halligan, Houck, and Monk (2009) utilized tasks measuring working 
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memory, inhibition, and attention through N-back, Stroop, and Trail-Making, 
respectively, and found that sleep latency and efficiency were correlated with cognitive 
performance.  Other sleep-related factors, such as daytime sleepiness and napping, are 
associated with cognitive impairment.  These sleep-related factors could be due to other 
disorders; for example, in patients with sleep apnea, breathing pauses during sleep may 
cause repeated anoxia, leading to cerebral white matter change and subsequent cognitive 
decline (Xu et al., 2011).   
Studies examining both verbal and non-verbal memory in older adults 
demonstrated memory impairments in relation to sleep duration.  Verbal short-term and 
general memory impairments were found in older adults sleeping longer than 8 hours 
after controlling for covariates, such as depression, medication, and age, (Schmutte et al., 
2007; Xu et al., 2011).  Mograss, Guillem, and Stickgold (2010) conducted a study 
examining face recognition and sleep duration and found that long sleepers failed to 
retain the old information in face recognition tasks.  Interestingly, long and average 
sleepers demonstrated a positive correlation in terms of accuracy in face recognition tasks 
and sleep duration, although short sleepers demonstrated a negative correlation and 
higher accuracy compared to both average and long sleepers.  The researchers suggested 
that the short sleepers accumulated NonREM (Rapid Eye Movement) slow-wave sleep 
more rapidly at the beginning of the night, resulting in better performance in the face 
recognition tasks compared to average and long sleepers.  It is suggested that the 
transition and duration of the stages of sleep are related to memory consolidation and 
potentiated networks, explaining the short sleepers’ faster reaction times and better 
memory performance (Mograss et al., 2010). 
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Disrupted sleep may cause sleepiness, which may result in reduced vigilance; this 
reduced vigilance may in turn negatively influence executive functioning (Blackwell et 
al., 2011).  Long sleepers have demonstrated decreased performance in vigilance tasks 
(Blackwell et al., 2011; Taub, Globus, Phoebus, & Drury, 1971; Taub & Berger, 1969) 
and tend to make more omissions in cognitive tasks (Mograss et al., 2010; Taub & 
Berger, 1969).  Younger and older adults long sleepers also demonstrate decreased 
psychomotor speed and cognitive functioning related to verbal memory (Kronholm et al., 
2009).   
Cognitive aging is the notion that not everyone experiences the same rate of 
cognitive decline (Ferrie et al., 2011).  Ferrie et al. (2011) found as much as a 3-8 year 
increase in cognitive aging when measuring cognitive functioning in older adults who 
slept greater than 8 hours per night.  Faubel et al. (2009) found that individuals who slept 
11 hours or more per night demonstrated a 10-year increase in age on a mental status 
exam, even after adjusting for confounds such as sleep apnea and health-related quality of 
life.  Additionally, associations were discovered between sleep fragmentation and mental 
status scores related to memory and naming (Blackwell et al., 2011).   
Blackwell et al. (2006) found that objectively measured sleep was related to 
poorer cognition, but not total sleep time.  The researchers found that higher sleep latency 
in women was associated with higher risk of cognitive impairment, as was higher wake 
after sleep onset; these results suggest that disturbance of sleep, rather than sleep 
quantity, may affect cognition (Blackwell et al., 2006).  Moreover, sleep quality, timing, 
and amount are all potential contributors to individual variability in age-associated 
cognitive impairment (Nebes et al., 2009).  Nebes et al. (2009) suggested different 
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mechanisms, such as cortical atrophy, white matter pathology, and reductions in 
neurotransmitter binding, which may explain the age-associated individual differences in 
cognitive decrements.   
 It can be posited that longer sleep duration may be caused by cognitive deficits, 
however, longitudinal studies are able to show changes in sleep duration, which provides 
evidence that this reverse causality is unlikely (Ferrie et al., 2011).  Another plausible 
hypothesis is that decreased cognitive performance may be due to internal factors 
deteriorating the brain, which is reflected in sleep duration and efficiency in cognitive 
processing (Kronholm et al., 2011).  Other theories for poor cognitive performance in 
longer sleepers include the following: fatigue or tiredness, as individuals who sleep 
longer may not be benefiting from the additional time in bed; some underlying 
neurological disease; passive way of life (Kronholm et al., 2009); and prolonged 
elevation of plasma melatonin levels in the daytime (Aeschbach et al., 2003), which 
could inhibit memory formation (Kronholm et al., 2009; Rawashdeh et al., 2007).   
1.9 RELATIONSHIPS BETWEEN MECHANISMS  
Associations between longer duration of sleep and individual factors, such as 
inflammation, mood/emotion, and cognitive impairment, have been established in the 
literature.  It is important to note that not only are there correlations between longer sleep 
duration and physiological and psychological factors, many of the factors are 
intercorrelated.  For example, inflammation is related to mood and emotion, as well as 
cognitive performance; cognitive performance is also associated with mood and emotion.  
However, the causative nature and interactions of these relationships is not well 
understood. 
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1.9.1 Inflammation and emotional/mood disturbances. Systemic inflammation 
is related to pain and discomfort, and both inflammation and physical pain are associated 
with emotional or mood disturbances.  When investigating the psychological differences 
between long and short sleepers, Hartmann et al. (1972) found that long sleepers tended 
to have more complaints of body aches and pains, as well as mild to moderate neurotic 
issues.  They reported that long sleepers were worriers and more likely than short 
sleepers to be anxious and mildly depressed (Hartmann et al., 1972).  Studies examining 
patients with inflammatory diseases have found associations between pain, depression, 
and sleep disturbances (Li, Zhang, Zhu, Du, & Huang, 2012; Wolfe, Michaud, & Li, 
2006).  Additionally, studies in the general population have shown that poorer quality of 
sleep is correlated with depression (Sayar, Arikan, & Yontem, 2002). 
 There is a growing body of evidence showing associations between depression 
and increased systemic inflammation.  More specifically, research shows that there is an 
association between depression and up-regulated inflammatory responses, such as 
increased acute phase reactive proteins and pro-inflammatory cytokines.  A possible 
mechanism by which pro-inflammatory cytokines impact mood is through the induction 
of the indoleamine-2, 3-dioxygenase (IDO) enzyme by pro-inflammatory cytokines.  IDO 
catalyzes the synthesis of kynurenine, which is a metabolite that comes from dietary 
tryptophan.  Since tryptophan is necessary for the synthesis of serotonin and melatonin, 
the resulting depletion of tryptophan might contribute to symptoms of depression 
(Penninx et al., 2013).   
Furthermore, IDO activation increases the synthesis of tryptophan catabolites 
(TRYCATs), an N-methyl-D-aspartate (NMDA) agonist.  Higher levels of TRYCATs, 
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which have been reported in depressed patients, may disturb neurotransmitter responses 
along glutamatergic pathways, causing hippocampal damage.  This damage could 
contribute to symptoms of depression.  Higher levels of TRYCATs in depressed patients 
have also been associated with somatic health complaints, such as pain (Penninx et al., 
2013).  In a recent review, Penninx et al. (2013) found that individuals with atypical 
depression, marked by hypersomnia, fatigue, and mood reactivity, had higher levels of 
inflammation compared to other types of depression.  It could be posited that individuals 
with atypical depression experience increased inflammation due to spending more time in 
bed, which could also explain the increased fatigue and hypersomnia.  Long time in bed 
may lead to increased sleep fragmentation and decreased sleep depth (Youngstedt & 
Kripke, 2004), which is correlated with both daytime fatigue and increased inflammation 
(Thomas et al., 2011). 
There is an association between anxiety and increased systemic inflammation.  A 
recent study found that men who had a current anxiety disorder also had increased CRP 
levels, and both men and women with late onset of anxiety displayed low-grade systemic 
inflammation.  The relationship between increased inflammation and anxiety could be 
explained by confounds such as poor lifestyle behaviors, subclinical cardiovascular 
disease preceding both inflammation and anxiety, or immune dysregulation.  However, it 
is unclear of the causal direction of immune dysregulation (Vogelzangs et al., 2013).  
Additionally, Li et al. (2012) found an association between poor sleep and increased 
symptoms of depression, anxiety, and pain in individuals with ankylosing spondylitis, a 
chronic inflammatory disease.  Poor sleep, caused by sleep disruption, fragmentation, or 
restriction, causes increased sensitivity to pain, or hyperalgesia.  Since the pain threshold 
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is lowered and the pain signals are amplified, patients experience increased attention to 
pain and further disrupted sleep (Li et al., 2012).  Other confounding factors contributing 
to the relationship between inflammation and mood include the interaction between 
inflammation, mood, and cognitive function. 
1.9.2 Inflammation and cognitive function. Increased levels of inflammation 
have been associated with cognitive decline in older adults (Gimeno et al., 2008; Weaver 
et al., 2002).  As previously discussed (see “Inflammation and emotional/mood 
disturbances”), the impact of the depletion of tryptophan, which is needed for the 
synthesis of melatonin and serotonin, could impact both depression (Penninx et al., 2013) 
and memory.  Individuals who sleep longer may have prolonged elevation of plasma 
melatonin levels in the daytime (Aeschbach et al., 2003), which could inhibit memory 
formation (Kronholm et al., 2009; Rawashdeh et al., 2007).  Inflammation in the 
hippocampus may lead to deficits in learning and memory (Monje, Toda, & Palmer, 
2003); hippocampal long-term potentiation (LTP) is considered to be a cellular model for 
learning and memory (Bellinger, Madamba, Campbell, & Siggins, 1995).  One theory, 
primarily an Alzheimer’s disease model, attempts to explain why inflammatory cytokines 
have a negative impact on LTP: the theory proposes that β-amyloid protein-induced 
secretion of IL-6 is increased after a self-amplifying neurometabolic cascade and results 
in neuronal injury (Weaver et al., 2002).   
In an attempt to further understand how inflammation in the hippocampus is 
related to LPT, Bellinger et al. (1995) placed electrodes in the dentate gyrus granule cell 
layer and the dentate molecular layer of mice with detectable levels of IL-6 gene 
expression, and those with no gene expression.  LTP was elicited and evoked potentials 
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in hippocampal slices were examined.  It was discovered that the transgenic mice had 
significantly reduced dentate mean LTP.  It has been postulated that, in cognitive 
disorders associated with viral infection, IL-6 could be a contributing factor since IL-6 
has been shown to reduce NMDA-mediated toxicity in the hippocampus.  One hypothesis 
as to why LTP is reduced is that IL-6 may inhibit NMDA receptor function or NMDA-
mediated second messenger systems.  Bellinger et al. (1995) suggested that short- and 
long-lasting neuronal plasticity can be disrupted by the over-expression of cytokines, 
which could lead to a profound impact on cognitive function.  Furthermore, inflammation 
not only inhibits neurogenesis, it has also been found that neurogenesis can be restored if 
inflammation is blocked (Monje et al., 2003).   
Gimeno et al. (2008) found that both CRP and IL-6 are associated with low 
cognitive performance and decline in older adults.  More specifically, associations were 
found of CRP with inductive reasoning and vocabulary, whereas IL-6 was related to 
fluency.  One explanation for these results is that the differences in cognitive function are 
due to activation of different regions in the brain; for example, the prefrontal cortex is 
involved with inductive reasoning, the frontal and temporal lobe is related to tasks of 
verbal fluency, and the left front lobe is involved with verbal ability (Gimeno et al., 
2008).  Moreover, Weaver et al. (2002) also conducted a longitudinal study and reported 
that IL-6 predicted increased risks for cognitive decline at follow-up visits.  The 
researchers found that high levels of IL-6 were associated with poorer baseline cognitive 
function (Weaver et al., 2002).  A recent study discovered a negative correlation between 
IL-6 levels and cognitive performance in depressed and healthy older adults; recall ability 
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and encoding ability decreased as IL-6 levels increased (Elderkin-Thompson, Irwin, 
Hellemann, & Kumar, 2012). 
1.9.3 Emotional/mood disturbances and cognitive function. Associations 
between cognitive decline and depression (Bielak et al., 2011), as well as anxiety (Bunce, 
Batterham, Mackinnon, & Christensen, 2012), in older adults have been well-established.  
As many researchers question the causal direction of cognitive decline and depression, 
Bielak et al. (2011) used temporal models over a 15 year period to conclude that 
symptoms of depression predicted declines in perceptual speed in older adults.  The 
analysis was repeated after removing participants who possibly had dementia, and the 
same pattern was found.  However, when Bunce et al. (2012) removed possible dementia 
and mild cognitive impairment data, their initial significant associations of depression 
symptoms and cognitive variables became insignificant.  Interestingly, the associations 
between anxiety and cognitive variables increased in strength.  There are several 
hypotheses that attempt to explain the relationship between depression and dementia, and 
include changes in inflammation in the brain, increased cortisol production that causes 
hippocampal atrophy, vascular disease, and decreased nerve growth factor (Bunce et al., 
2012).   
Although the potential presence of dementia complicates the relationship between 
cognition and depression, other mechanisms have been suggested for the link between 
cognition and depression.  For example, it is hypothesized that an individual with 
declining cognitive abilities may react to this awareness of declining ability by 
developing symptoms of depression.  It is also proposed that depression may be a risk 
factor for decreased cognitive performance (Singh-Manoux et al., 2010).  Singh-Manoux 
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et al. (2010) suggested that the depression as a risk factor for cognitive decline may 
explain the results of their study, which found an association between depression and 
decreased cognitive ability in older adults.  However, in contrast to other proposed 
hypotheses, vascular disease was not shown to be a factor in the relationship between 
depression and cognitive ability (Singh-Manoux et al., 2010). 
It has already been established that there are associations between levels of 
systemic inflammation and cognitive performance.  Elderkin-Thompson et al. (2012) 
make the case that memory encoding performance can be predicted by biomarkers of 
inflammation (e.g. IL-6), and that poor performance can be mistaken for mild cognitive 
impairment or dementia.  It is suggested that this immunologic imbalance could result in 
inaccuracies in determining older adults’ cognitive abilities (Elderkin-Thompson et al., 
2012).  Sleep is also a factor in terms of cognition and mood disturbances, especially in 
older adults.  Depressive symptomatology may be a mediating variable in terms of 
cognitive decline in older adults who experience sleep disturbances (Jelicic et al., 2002).   
1.10 TIME IN BED EXTENSION IN OLDER ADULTS  
Age-related changes in sleep duration are likely related to age-related changes in 
the circadian sleep-wake rhythm (Prinz, Vitiello, Raskind, & Thorpy, 1990).  Even with 
these changes in sleep duration, many older adults voluntarily tend to spend more time in 
bed as a result of compensating for age-related sleep disturbances (Carskadon et al., 
1982; Prinz et al., 1990) or simply out of habit (Youngstedt et al., 2009).  Furthermore, 
(Carskadon et al., 1982) found that older adults tend to have substantially more 
fragmented sleep, and the decreased continuity of sleep was highly correlated with 
daytime well-being.  There is evidence that sleep restriction benefits overall well-being 
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and sleep quality, improving both sleep depth and continuity (Hoch et al., 2001), and may 
ultimately lead to reducing mortality and morbidity associated with long sleep 
(Youngstedt et al., 2009).  Even with evidence of the potential hazardous effects of long 
sleep or long time in bed in older adults, there are still conflicting opinions on the 
associations. 
On the other hand, extending time in bed could beneficially facilitate more sleep.  
Associations have been found between increased pro-inflammatory responses elicited by 
sleep disturbances resulting in loss of sleep (M. R. Irwin, Carrillo, & Olmstead, 2010; M. 
R. Irwin, Wang, Campomayor, Collado-Hidalgo, & Cole, 2006).  These associations may 
be the mechanism by which poor sleep quality or sleep loss accelerates morbidity in 
aging.  Because of this evidence of short sleep and its relationship to increased 
inflammation, it is plausible that extending sleep may result in decreased inflammation.  
Older adults may be more vulnerable to the risks of extreme sleep durations, such as short 
sleep, as older adults have shown the highest mortality rates related to sleep duration 
(Youngstedt & Kripke, 2004). 
However, it is plausible that sleep extension may have hazardous effects on older 
adults.  It has been demonstrated that healthy adults with reduced sleep efficiency and 
prolonged sleep latency had a two-fold elevated risk of mortality compared to normal 
sleepers (Dew et al., 2003).  Additionally, extension of sleep could produce greater sleep 
fragmentation, mimicking sleep loss.  Disordered sleep, in association with a decrease in 
sleep depth, is associated with increased inflammation (Irwin et al., 2004).  Aging is 
correlated with increased nocturnal wakefulness (Bliwise, 1993) and increased time in 
29 
bed (Hoch et al., 2001; Prinz et al., 1990), potentially leaving older adults even more 
vulnerable to risks of mortality and morbidity.   
1.11 CONCLUSION  
Long sleep, or long time in bed, is associated with mortality and several 
morbidities.  It is clear that older adults may be more vulnerable to the effects of long 
sleep duration.  Although the mechanisms for which long sleep is hazardous are unclear, 
randomized controlled trials will provide more light on the impact of experimentally 
extending sleep in older adults.  The results of an experimental study of sleep extension 
have important public health relevance, as extended sleep could contribute to mortality 
and poor health in older adults.  Due to the growing evidence of the harmful effects of 
long sleep duration, it was hypothesized that increased sleep duration would predict 
unhealthier physiological measures, decreased mood state, and declined cognitive 
performance.  Additionally, it was hypothesized that increased sleep disturbances would 
predict unhealthier physiological measures, decreased mood state, and declined cognitive 
performance. 
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CHAPTER 2 
METHODS 
2.1 DESIGN OVERVIEW  
Following a baseline week, participants were randomized to one of two three-
week treatments: (1) a control treatment, in which participants followed a fixed schedule 
in which their time-in-bed (TIB) was the same as their median baseline TIB; and (2) a 
sleep extension treatment, in which participants were asked to follow a fixed sleep 
schedule in which their TIB was 2 hours longer than their median baseline TIB.  After 1 
week of recovery, participants repeated the 1-week baseline and crossed over to the other 
treatment.  Measures were subjected to a principal components analysis (PCA) to reduce 
cases to adjust for the overlapping variance among similar measures.  The factor scores 
generated from the PCA were used in multiple linear regression analyses in order to 
generate associations between sleep and the physiological and psychological variables.   
2.2 PARTICIPANTS AND SCREENING  
Fourteen older (50-79 y), healthy adults who reported sleeping 6-8 h were 
randomized in the crossover study.  Three participants dropped out of the study due to 
schedule changes and/or time constraints.  Ten older adults (1 male; M=64.90±4.82 
years) completed the study and were assessed on cognitive, emotional, and inflammatory 
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measures in a cross-over design (median sleep vs. sleep extension).  See Figure 2.1 for an 
enrollment summary of the participants enrolled on the study.  Participants were recruited 
via word-of-mouth, flyers, advertisements, retirement communities, and University of 
South Carolina press releases.  Participants who completed our ongoing study of sleep 
restriction in older adults were notified about the study.  Individuals who were excluded 
from our ongoing study, who might have met the inclusion criteria of the proposed study, 
were notified about the study. 
The first screen occurred via a phone interview to establish that prospective 
participants were between 50-79 years of age, reported good health (no significant health 
conditions), and that they normally slept between 6-8 hours per night.  Interested 
participants who met the age, health, and sleep requirements were invited to the 
laboratory to complete questionnaires to further determine eligibility.  Exclusions 
included recent shiftwork (previous 2 months) or transmeridian travel (previous 4 weeks) 
or plans of either during the study period; moderate depression [(Patient Health 
Questionnaire (PHQ-9) ≥ 10; (Kroenke, Spitzer, & Williams, 2001; Kroenke, Spitzer, 
Williams, & Löwe, 2010)] suicidality [(Beck Scale for Suicide Ideation (BSS) >11; Beck, 
Kovacs, & Weissman, 1979)]; cognitive impairment [(Mini-Mental State Examination 
(MMSE) ≤ 26; Cockrell & Folstein, 1988); use of hypnotics or other medications to 
promote sleep; any medical, neurologic, or psychiatric illness causing long sleep; factors 
associated with significant changes in inflammation (a key outcome variable), including 
several medical disorders (e.g., rheumatoid arthritis), medications (e.g., steroids) current 
smoking, an obese body mass index (BMI >33), and greater than 3 hours of moderate to 
vigorous exercise per week. 
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Prospective participants who met the initial criteria were invited to the laboratory 
for further study orientation and to sign a written informed consent form approved by the 
University of South Carolina Institutional Review Board.  Prospective participants were 
interviewed about their sleep, health, and behavioral patterns (i.e. self-reported usual 
sleep patterns, mental health, general health, etc.), and completed questionnaires (PHQ-9 
and BSS) in order to rule out any of the previously mentioned exclusion criteria.  In order 
to ensure that participants had the necessary level of cognitive function, the MMSE 
(exclusion for score of ≤ 26; Cockrell & Folstein, 1988) was administered.  For further 
screening, Imran Iftikhar, MD, a sleep physician and Associate Professor of Medicine at 
the University of South Carolina School of Medicine, performed an interview to screen 
for sleep disorders.  Demographics were collected at the time of consent, and a list of all 
medications taken was requested.  See Figure 2.2 for a flowchart of the screening 
appointments. 
2.3 BASELINE  
A 1-week baseline before each treatment assessed pre-treatment measures, and 
also served as a final screen to establish that the participants slept 6-8 hours.  Participants 
were excluded if actigraphic TIB was outside of the 6-8.5 hour range.  During baseline, 
participants were asked to follow their usual sleep-wake schedules.  
2.4 EXPERIMENTAL TREATMENTS AND RANDOMIZATION  
Following baseline, participants were randomly assigned to one of two, 3-week 
treatments: (1) extended TIB, or (2) fixed TIB: Median Sleep. The randomization was 
stratified by median duration of actigraphic baseline (< 7 vs. ≥ 7 h).  Following 
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randomization, participants completed 5-point Likert scale questions regarding their 
expectancy of experiencing changes in sleep, mood, daytime alertness, and health. 
2.4.1 Extended TIB condition. In the extended TIB treatment, participants were 
asked to follow a fixed sleep schedule, in which their time in bed (TIB) was 2 hours 
longer per night than their actigraphic median TIB during the baseline week.  This was 
accomplished by advancing bedtime, delaying arising time, or some combination of these 
changes in accordance with the preferences and sleep tendencies of each participant.  For 
example, delaying arising time was favored for a participant who preferred to sleep 
longer in the mornings.   
2.4.2 Fixed sleep condition. In the fixed sleep treatment, participants were asked 
to follow a fixed sleep schedule, in which their TIB was the same as their median TIB 
during the baseline week.  This treatment served as a control for a fixed TIB, believed to 
be beneficial, as well as for behavioral artifacts, such as expectancy, Hawthorne, and 
demand effects. 
2.5 CROSS-OVER DESIGN  
After completion of the baseline and 3-week study, participants completed a 1-
week recovery period to avoid carry-over effects.  Participants then underwent a second 
1-week baseline and were crossed-over to the other treatment: participants who were 
initially randomized to the extended TIB group then underwent the fixed TIB treatment; 
participants who were initially randomized to the fixed TIB group then began the 
extended TIB treatment.  Baseline and treatment measures were repeated as described 
previously. 
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2.6 MEASURES  
 Table 2.1 displays the time points in which each assessment occurred.  Each of 
the 3-week treatments was preceded by a one-week baseline.  Cognitive measures were 
assessed at the first baseline and after each treatment condition.  Clinician-administered 
mood measures were assessed after each baseline and treatment condition.  Blood 
pressure, heart rate, sleepiness, depressive symptoms, and anxiety symptoms were 
assessed weekly.  Inflammation, glucose, and cholesterol measures were assessed 
following both treatment conditions. 
2.6.1 Sleep and sleepiness assessment. Throughout each baseline and each 3-
week treatment, participants wore wrist actigraphic monitors (Phillips Respironics 
Actiwatch Spectrum device) for continuous assessment of sleep-wake patterns.  
Participants were given the option to continue wearing the actigraphy device during the 
1-week recovery period.  For those who continued to wear the device, wrist actigraphic 
recordings were maintained during the recovery period to ensure participants maintained 
pre-experiment sleep patterns.  
Illumination recording allowed estimates of TIB accurate to 1 minute.  
Advantages of actigraphy are the applicability to home settings and the larger number of 
nights that can be recorded, which improves the stability of estimates in the presence of 
night-to-night variability.  Actigraphy, which is a highly validated and reliable alternative 
to laboratory polysomnography (PSG), is a cost-effective alternative PSGs.  For longer-
term studies, daily sleep estimation with actigraphy may be preferable to PSG recording, 
which typically is restricted to 1 or 2 nights.  Total sleep time (TST), TIB, sleep 
fragmentation index, sleep efficiency, and sleep onset latency (SOL) were also assessed.  
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Actigraphic algorithms calculated sleep fragmentation index as the sum of the percentage 
of mobile bouts and percentage of immobile bouts less than 1 minute to the number of 
immobile bouts.  Sleep efficiency was calculated by the actigraph as the percentage of 
time spent asleep within the TIB interval. 
In a daily morning sleep diary, participants reported time in bed, wake time, 
quality of sleep, etc.  To measure subjective sleepiness, participants completed the 
Epworth Sleepiness Scale
 
(ESS; Johns, 1991) at the end of each baseline week and each 
treatment week.  Higher scores on the ESS represent increased level of daytime 
sleepiness.  The Multidimensional Assessment of Fatigue (MAF) Scale (Belza, Henke, 
Yelin, Epstein, & Gilliss, 1993) was used to measure fatigue at the end of each baseline 
week and each treatment week.  Higher scores on the MAF indicate increased level of 
fatigue.   
2.6.2 Cognitive assessment. At the initial baseline and at the end of each 3-week 
treatment, working memory, sustained attention, and executive function were assessed 
with a cognitive performance battery, which consisted of verbal and non-verbal working 
memory tasks, Psychomotor Vigilance Test (PVT), Stroop Test (Stroop, 1935), and the 
Trail Making Test (TMT).  The Stanford-Binet Intelligence Scale, 5
th
 edition (SB5; Roid, 
2003) includes two working memory tasks: Block Pattern Memory Task (BPMT), which 
tests nonverbal working memory, and the Sentence Memory Task (SMT), which tests 
verbal working memory.  Composite scores were obtained by scoring both the verbal and 
nonverbal tasks, but individual scores were determined to compare verbal and nonverbal 
working memory ability.  One advantage of the SB5 is that it contains a sample of 
normative data from older adults (85+ years).  In order to maintain the integrity of the 
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tests, the SB5 working memory assessments were administered by two blinded clinical 
psychology doctoral students, Katherine Knies and Betsy Davis.  The clinical students 
were supervised by Dr. M. Michele Burnette, Ph.D. 
Additionally, working memory was also assessed using the valid and reliable 
Automated Reading Span (verbal working memory) and Automated Operation Span tasks 
(nonverbal working memory; Unsworth, Heitz, Schrock, & Engle, 2005).  The 
Automated Reading Span task requires participants to read sentences while also trying to 
remember strings of unrelated letters; the overall test score and errors (speed and 
accuracy) were recorded.  The total score comprised the sum of all the correctly recalled 
sets of letters.  The Automated Operation Span task requires participants to solve math 
equations while also remember letters; the scoring for this task was the same as the 
scoring for the Automated Reading Span task. 
The PVT, which is sensitive to aging and changes in sleep (Drummond et al., 
2005), was used to assess changes in reaction time associated with state dependent 
changes in sustained attention.  Participants used the PVT device to press a button as 
quickly as possible when each visual stimulus was presented.  Sustained attention 
measured via changes in psychomotor vigilance has a compelling history in the extended 
sleep literature (Blackwell et al., 2011; Kronholm et al., 2011; Taub, Globus, Phoebus, & 
Drury, 1971; Taub & Berger, 1973).  Metrics that were assessed included median 
reaction time (RT), the fastest 10% of responses, the slowest 10% of responses, the 
number of response “lapses” (RT > 500 ms), and standard deviation of responses.   
The Stroop Color-Word Test (Stroop, 1935) is a reliable and useful tool used in 
psychology.  The basic paradigm of the Stroop test consists of a basic task (e.g. reading 
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names of colors presented in blank ink) and comparing the performance on the basic task 
with performance on a comparable task where a habitual response is suppressed (e.g. 
reading names of colors presented in various ink colors, incongruent to the color name).  
The increased time needed to complete the comparable task compared to the basic task is 
called the “Stroop interference effect,” and is considered to be a measure of executive 
functioning and cognitive control and flexibility (Van der Elst, Van Boxtel, Van 
Breukelen, & Jolles, 2006).  The Stroop test is used in many areas of sleep research, 
including long sleep duration (Nebes et al., 2009), sleep deprivation (Cain, Silva, Chang, 
Ronda, & Duffy, 2011; Tucker, Whitney, Belenky, Hinson, & Van Dongen, 2010), sleep 
restriction (Philip et al., 2012), sleep fragmentation (Ferri et al., 2010), obstructive sleep 
apnea (Lee et al., 2011), narcolepsy (Moraes, Rossini, & Reimão, 2012), and insomnia 
(Spiegelhalder, Espie, Nissen, & Riemann, 2008).  Interference was measured by 
subtracting the average time of the first two subtasks completion from the average time of 
third subtask completion (Interference = [(Stroop I + Stroop II) / 2] – Stroop III; 
Valentijn et al., 2005; Van der Elst et al., 2006).  Reaction times and errors were also 
evaluated.   
The TMT (part A) requires participants to draw lines (trails) in order from 
randomly placed circles numbers (1 to 2 to 3, etc.).  Part B requires participants to draw 
lines (trails) alternating between numbers and letters (1 to A to 2 to B to 3 to C, etc.).  
The TMT (part B) has been shown to be highly sensitive to cognitive aging and is a valid 
measure of executive function (Oosterman et al., 2010).  The TMT (part B) has been used 
in several studies of sleep duration (Blackwell et al., 2011; Nebes et al., 2009) and sleep 
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quality (Blackwell et al., 2006).  Reaction times of trail-making completion were 
evaluated.  
2.6.3 Depression, anxiety, and mood assessment. During both baselines, and at 
the end of each treatment, participants were assessed with the clinician-administered 
Hamilton Anxiety Rating Scale (HAM-A; Hamilton, 1959) and Hamilton Depression 
Rating Scale (HAM-D; Hamilton, 1960).  The HAM-A and HAM-D were administered 
by blinded clinical psychology students, who were under the supervision of a licensed 
psychologist.  
  At the end of each baseline period, and the end of each treatment week, 
participants completed the self-administered Beck Depression Inventory (BDI-II; Beck et 
al., 1996)
 
and the Spielberger State Trait Anxiety Inventory (STAI Form Y-1; 
Spielberger, 1989). 
 
The Beck Scale for Suicide Ideation (BSS; Beck et al., 1979)
 
was 
administered if a participant indicated suicidal thoughts on the on the BDI-II.  No 
participants indicated suicidal thoughts on the BDI-II.  With the emergence of moderate 
depression (BDI ≥26 or HAM-D ≥20), moderate anxiety (HAM-A ≥ 21), and/or 
significant suicide ideation (BSS>11), the participant was to be discharged from the 
experiment and referred to appropriate care at the Psychology Services Center at the 
University of South Carolina.  No participants demonstrated moderate depression, 
anxiety, or suicide ideation at any point in the study (including screening). 
Additionally, participants completed a daily diary consisting of Likert scale 
questions pertaining to mood.  Participants rated how they felt the previous day; a score 
of zero represented “normal” mood, -3 represented “low” mood, and +3 represented 
“elated” mood.  Significant impairment (consistent “low” ratings) would have activated 
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further assessment, possible termination, and referral for care; however, no participants 
indicated significant impairment on any mood measures. 
2.6.4 Symptoms assessment. At each baseline and the end of each 3-week 
treatment, symptoms were assessed with the Systematic Assessment for Treatment and 
Emergent Events (SAFTEE; Moynihan, 1983), which is a checklist adaptation of a 
comprehensive National Institute of Mental Health interview used to detect and monitor 
the side effects of treatments.  Ninety-four individual symptoms are grouped into 17 
SAFTEE-defined categories, such as head, eyes, chest, etc.  The SAFTEE was used in 
order to determine no adverse effects of treatment during the study.  No adverse effects 
were reported during the study. 
2.6.5 Physiological measures. At the end of each 3-week intervention, 
participants underwent a 12-hr fast and blood draw (7 ml) to obtain lipid levels 
(lipoprotein, low-density lipoprotein, very low-density lipoprotein, and triglycerides), 
glucose, and an inflammation marker (CRP).  Fasting blood draws were conducted at the 
Lexington Medical Center’s (LMC) Clinical Pathology Laboratory in West Columbia, 
SC.  The LMC laboratory collected, processed, stored, and analyzed samples.   
Following a 10-minute seated resting period, systolic and diastolic blood pressure, 
as well as heart rate, were recorded at the beginning of each weekly appointment with an 
Omron RS8 automatic wrist blood pressure monitor.  The Omron RS8 device is a 
validated, easy to use blood pressure monitoring device (Takahashi, Yoshika, & Yokoi, 
2013).  At the beginning of each participant’s weekly appointment, the device was placed 
on the participant’s non-dominant wrist below the ulna wrist bone, per the manufacturer’s 
instructions.  The participant sat quietly for 10 minutes, without legs or ankles crossed.  
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After 10 minutes, the blood pressure and heart rate readings were recorded, and then 
repeated after 2 minutes.  If an error or large difference occurred between the two 
readings (i.e. >10 units), the reading was taken a third time.  The averages of the 
recordings were reported. 
2.6.6 Marker of inflammation. CRP was assayed at LMC’s Clinical Pathology 
Laboratory in West Columbia, SC, after each treatment period.  Recent infection/illness 
resulted in interpolation of data based on group values (n=2; see “Data Screening”).  
Participants were carefully screened for alcohol consumption, smoking history, body 
mass index (BMI), physical activity, and use of medications (antidepressants, statins, and 
non-steroidal anti-inflammatory drug (NSAID; O’Connor et al., 2009; O’Connor & 
Irwin, 2010), as these factors may impact inflammatory marker results.
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Figure 2.1. Study Enrollment at Flow Chart.  Mean age and standard deviation are 
reported for the randomized and completed stages. 
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Figure 2.2. Screening Process Flow Chart. Screening process began a phone interview to 
ensure general inclusion criteria are met (age, sleep, etc.); first screening appointment 
included consent, questionnaires (Patient Health Questionnaire ≥ 10, Beck Scale for 
Suicide Ideation >11), screening interview (questions regarding health and behavior), and 
cognitive health assessment (Mini-Mental State Examination ≤ 26); second screening 
appointment included interview with sleep physician to screen for sleep disorders.
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Table 2.1. Assessments Measured at each Time Point 
Experimental Measures during Baseline and Treatment Groups Cross-Over Study; Recovery week occurs during Week 5. 
Baseline 
 
Treatment (Control vs. Sleep Extension) 
  
Follow-Up Appts. 
   
Follow-Up Appts. 
 
Condition Follow-Up 1 
Daily Week 1 
 
End Week 1 
 
Daily Weeks 2-4 
 
End Week 2-4 
 
End Week 4 
Actigraphy 
 
Cognitive Battery 
 
Actigraphy 
 
Sleepiness 
 
Blood Draw 
Sleep Diary 
 
Sleepiness 
 
Sleep Diary 
 
Fatigue 
 
 Mood Diary 
 
Fatigue 
 
Mood Diary 
 
Depression* 
 
Cognitive Battery  
  
Depression* 
 
  
Anxiety 
  
  
Anxiety 
   
BP HR 
 
Symptoms 
  Symptoms 
 
  
   
    BP HR 
 
  
   Baseline 
 
Treatment (Control vs. Sleep Extension) 
  
Follow-Up Appts. 
 
  
Follow-Up Appts. 
 
Condition Follow-Up 2 
Daily Week 6 
 
End Week 6 
 
Daily Weeks 7-9 
 
End Week 7-9 
 
End Week 9 
Actigraphy 
 
Sleepiness 
 
Actigraphy 
 
Sleepiness 
 
Blood Draw 
Sleep Diary 
 
Fatigue 
 
Sleep Diary 
 
Fatigue 
 
 Mood Diary 
 
Depression* 
 
Mood Diary 
 
Depression* 
 
Cognitive Battery  
  
Anxiety 
 
  
Anxiety 
  
  
Symptoms 
   
BP HR 
 
Symptoms 
    BP HR             
Note. Sleepiness (weekly): Epworth Sleepiness Scale (ESS); Depression: Beck Depression Inventory (BDI-II; weekly), Hamilton Depression 
Rating Scale (HAM-D; end of each baseline and end of each treatment); Anxiety: State Trait Anxiety Scale (STAI; weekly), Hamilton Anxiety 
Rating Scale (HAM-A; end of each baseline and end of each treatment); Cognitive Battery (end of first baseline and end of each treatment): Block 
Pattern Memory Task (BPMT), Sentence Memory Task (SMT), Automated Reading Span Task, Automated Operation Span Task, Trail Making 
Test (TMT), Psychomotor Vigilance Test (PVT), Stroop Test; Symptoms (end of each baseline and end of each treatment): Systematic Assessment 
for Treatment and Emergent Events (SAFTEE); BP (blood pressure) and HR (heart rate) assessed weekly; *Beck Scale for Suicide Ideation 
administered after screening if participant indicates suicidal thoughts on BDI-II
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CHAPTER 3 
RESULTS 
 Means and standard deviations for screening data are available in Appendix A.  
Means and standard deviations for raw and transformed data are available in Appendix B.  
In order to determine if time in bed (TIB) and total sleep time (TST) were extended, t-test 
comparisons were completed on the actigraphic variables.  These comparisons are 
available in Appendix C.  Additionally, principal components analyses (PCA) were 
completed on each set of independent and dependent variables in order to identify the 
distinct contributions of variance of each set of measures to the constructs of interest.  
Our constructs of interest were Sleep, Physiological Health, Cognition, and Mood.  
Multiple linear regressions were completed to determine predictive tendencies of the 
independent variables. 
3.1 DATA SCREENING  
Prior to analysis, sleep, cognitive, mood, and physiological measures were 
screened for equipment errors, accuracy of data entry, missing values, outliers, and fit 
between their distributions and the assumptions of multivariate analysis (including 
skewness and kurtosis) using SPSS.  Actigraph malfunction resulted in the loss of one 
week of an individual’s sleep data from the last habitual sleep week condition.  The sleep 
data for the week were replaced by the mean from the same participant’s two other 
habitual sleep weeks (week 7 and 8).  Actigraph computational error resulted in 
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consistent underestimation of SOL data, therefore, SOL data were removed from 
analyses.  Missing values of two participants for the SB5 at baseline and for the end of 
the habitual sleep condition were replaced by mean scores of participants during the same 
condition and in the same condition order.  Due to test malfunction, not enough data from 
the Automated Operation Span task were recovered for analysis.  More specifically, the 
task did not run correctly on the programming platform and generated an error, which did 
not allow the participant to complete the task.  Therefore, this test was dropped from 
further analysis.   
Missing values of one participant for the HAM-A and HAM-D for the end of the 
habitual sleep condition were replaced by mean scores of participants during the same 
condition and in the same condition order (unique subject from actigraphic data).  The 
single missing value of one response on the BDI was replaced by the mean response to 
the other BDI questions for that week.  Two participants reported infections during the 
blood draw at the end of the second condition; the two corresponding CRP cases were 
found to be univariate outliers.  The average of the CRP values of all participants in the 
same condition and in the same condition order was calculated and substituted for those 
values.   
All raw data were examined for univariate outliers.  Cases were considered to be 
univariate outliers if the values that were greater than 3 or less than -3 standard deviations 
from the mean.  Out of the 100 cases of blood measures data, no additional outliers were 
identified with these criteria.  Out of 400 sleep data cases, eight cases met these criteria 
and were replaced with mean values of participants in the same condition.  Out of the 300 
cognitive data cases, three cases met these criteria and were replaced with mean values of 
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participants in the same condition.  Out of the 320 cases of sleepiness and mood data, 
four outliers were identified as univariate outliers with these criteria and were replaced 
with mean values of participants in the same condition.  Out of 240 blood pressure and 
heart rate cases, one outlier was identified as a univariate outlier with these criteria and 
was replaced with mean value of participants in the same condition.  Out of 80 clinician-
administered mood assessments, one outlier was identified as a univariate outlier with 
these criteria and was replaced with mean value of participants in the same condition.  
Out of the total data set, less than 1.4% of all data were removed. 
To improve pairwise linearity and to reduce the extreme negative skewness and 
kurtosis, CRP, Stroop Interference scores, and PVT mean scores were logarithmically 
transformed.  Additionally, to reduce positive skewness in LDL and heart rate measures, 
the data were square root transformed.  BDI, STAI, ESS, and MAF difference scores 
were computed by subtracting baseline values from weekly data due to extreme skewness 
and kurtosis.  TMT A, TMT B, PVT number of lapses, and SB5 Sentence Memory Task 
violated the assumptions of skewness and kurtosis, but would not normalize with any 
transformation attempt (i.e. square root, log transformation, etc.).  Appendix D contains 
all of the transformed histograms to demonstrate correction of normality.   
3.2 DATA REDUCTION: PCA  
Given the small number of participants and the large number of measures with 
overlapping variance, principal components analysis was used to extract components 
describing unique portions of the data from the sleep, physiological, cognitive, and mood 
measures.  Reducing the variables minimized the impact of Type II errors by multiple 
comparisons.  Tables of correlation matrices that demonstrate overlapping relationships 
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between the raw measures are presented in Appendix C.  PCA generates factor scores for 
each individual case, which represent the estimates of the values that would be produced 
if the constructs could be directly measured.  These factor scores were then used for the 
multiple linear regression analyses.  Additional analyses of raw data would have been 
inappropriate and duplicate analyses, increasing the risk of Type II errors.  Clinician-
administered assessments (HAM-A and HAM-D), blood pressure, and heart rate were not 
subjected to the PCA analyses due to measurements being taken at different points than 
other mood and physiological data.  These data were directly subjected to multiple linear 
regressions. 
 3.2.1 Sleep components. The actigraphic measures (TST, sleep fragmentation, 
and sleep efficiency) were subjected to a PCA using ones as prior communality estimates.  
In order to compare the actigraphic measures to the physiological data, which was not 
collected at baseline, PCA was performed on the actigraphic measures without the 
baseline data.  However, the cognitive and mood data contained baseline measures.  To 
render the actigraphic data comparable to those dependent variables, a second PCA was 
performed including the baseline data.  Although the loadings varied slightly between the 
two extractions, the same components were obtained from both analyses. 
Actigraphic measures of all condition weeks except for baseline data were 
subjected to a PCA using ones as prior communality estimates.  The principal axis 
method was used to extract the components, and this was followed by a promax (oblique) 
rotation with Kaiser normalization.  The rotation was converged in 3 iterations.  Only the 
first two components displayed eigenvalues greater than 1, and the results of the scree 
test also suggested that only the first two components were meaningful.  Combined, 
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components 1 and 2 accounted for 85% of the total variance.  Measures and 
corresponding factor loadings are presented in Table 3.1.  In interpreting the component 
matrix, a measure was said to load on a given component if the factor loading was .50 or 
greater for that component, and was less than .50 for the other.  Using these criteria, four 
measures were found to load on the first component (sleep fragmentation, WASO, 
number of awakenings, and sleep efficiency), which was subsequently labeled the 
Disturbance component.  The Disturbance component represents disruptions of sleep; as 
the factor scores increase for this component, it represents increasingly disrupted sleep.  
Only one measure loaded on the second component (TST), so it was labeled TST.  These 
factors were used only for the physiological data collected from the blood draws, which 
were collected after each condition ended and not during any baseline conditions. 
Actigraphic measures with baseline data were subjected to a PCA using ones as 
prior communality estimates.  The principal axis method was used to extract the 
components, and this was followed by a promax (oblique) rotation with Kaiser 
normalization.  The rotation was converged in 3 iterations.  Only the first two 
components displayed eigenvalues greater than 1, and the results of the scree test also 
suggested that only the first two components were meaningful.  Combined, components 1 
and 2 accounted for 85% of the total variance.  Measures and corresponding factor 
loadings are presented in Table 3.2.  In interpreting the component matrix, a measure was 
said to load on a given component if the factor loading was .50 or greater for that 
component, and was less than .50 for the other.  Using these criteria, four measures were 
found to load on the first component (sleep fragmentation, WASO, number of 
awakenings, and sleep efficiency), which was subsequently labeled the Disturbance 
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component.  The Disturbance component represents disruptions of sleep; as the factor 
scores increase for this component, it represents increasingly disrupted sleep.  Only one 
measure loaded on the second component (TST), so it was labeled TST.   
3.2.2 Physiological components. Physiological measures, with the exception of 
blood pressure data and heart rate, were subjected to a PCA using ones as prior 
communality estimates.  Blood pressure data and heart-rate were collected at different 
time points than the rest of the data, which would have skewed the analysis based 
variability related to the collection times.  The principal axis method was used to extract 
the components, and this was followed by a promax (oblique) rotation with Kaiser 
normalization.  The rotation was converged in 3 iterations.  Only the first two 
components displayed eigenvalues greater than 1, and the results of the screen test also 
suggested that only the first two components were meaningful.  Combined, components 1 
and 2 accounted for 65% of the total variance.   
Measures and corresponding factor loadings are presented in Table 3.3.  In 
interpreting the component matrix, a measure was said to load on a given component if 
the factor loading was .44 or greater for that component, and was less than .43 for the 
other.  Using these criteria, three measures were found to load on the first component 
(CRP, glucose, and HDL), which was subsequently labeled the Cardiovascular Risk 
component.  The Cardiovascular Risk component represents risk of a cardiovascular 
event; as the factor scores increase for this component, it represents increased risk of a 
cardiovascular event.  Two measures loaded on the second component (Trig and LDL), 
which was labeled the Lipid Profile component.  As scores increase for the Lipid Profile 
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component, it represents a higher cholesterol levels and higher risk of developing heart 
disease.   
3.2.3 Cognition components. Eight cognition measures were subjected to a PCA 
using ones as prior communality estimates.  The principal axis method was used to 
extract the components, and this was followed by a promax (oblique) rotation with Kaiser 
normalization.  The rotation was converged in 5 iterations.  Only the first three 
components displayed eigenvalues greater than 1, and the results of the scree test also 
suggested that only the first two components were meaningful.  Combined, components 
1, 2, and 3 accounted for 75% of the total variance. 
Measures and corresponding factor loadings are presented in Table 3.4.  In 
interpreting the rotated factor pattern, a measure was said to load on a given component if 
the factor loading was .50 or greater for that component, and was less than .50 for the 
other.  Using these criteria, three measures were found to load on the first component 
(TMT parts A and B, and Stroop Interference scores), which was subsequently labeled 
the Executive Control (assisted with motor sequencing) component.  The Executive 
Control component represents control of executive functions; as the factor scores 
decrease for this component, it represents increased control of executive functions.  Three 
measures also loaded on the second component (Automated Reading Span, number of 
PVT lapses, and PVT reaction time), which was labeled the Vigilance component.  The 
Vigilance component represents concentration ability; as the factor scores decrease for 
this component, it represents increased ability to concentrate on a task.  Factor scores 
were reversed scored in order to provide a more comprehensible relationship.  Two 
measures also loaded on the third component (SB5 Block Pattern Memory Task and SB5 
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Sentence Memory Task), which was labeled the Working Memory component.  The 
Working Memory component represents working memory capacity; as the factor scores 
increase for this component, it represents increased working memory capacity.   
3.2.4 Mood and sleepiness components. Mood and sleepiness measures were 
subjected to a PCA using ones as prior communality estimates.  The principal axis 
method was used to extract the components, and this was followed by a promax (oblique) 
rotation with Kaiser normalization.  The rotation was converged in 3 iterations.  Only the 
first two components displayed eigenvalues greater than 1, and the results of the scree 
test also suggested that only the first two components were meaningful.  Combined, 
components 1 and 2 accounted for 70% of the total variance.   
Measures and corresponding factor loadings are presented in Table 3.5.  In 
interpreting the rotated factor pattern, a measure was said to load on a given component if 
the factor loading was .50 or greater for that component, and was less than .50 for the 
other.  Using these criteria, two items loaded on the first component (STAI and BDI), 
which was labeled the Mood component.  The Mood component represents subjective 
feelings of current mood state; as the factor scores decrease for this component, it 
represents more negative mood states.  Two items were found to load on the second 
component (ESS and MAF), which was subsequently labeled the Sleepiness component.  
The Sleepiness component represents subjective feelings of sleepiness and fatigue; as the 
factor scores increase for this component, it represents increased subjective feelings of 
sleepiness and fatigue.   
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3.3 STATISTICAL ANALYSES  
The major manipulation in the study was TIB.  In order to examine the effects of 
TIB on sleep, a paired samples t-test was performed comparing the normal and sleep 
extension groups’ actigraphic TIB data to verify the manipulation.  The TIB statistically 
significantly increased from 484.86±16.44 min in the normal sleep condition to 
555.06±33.59 min during the sleep extension condition, t(9)=-8.746, p<.0001.  Figure 3.1 
shows the average TIB in minutes for each group and Figure 3.2 shows the cross-over 
nature of the study for TIB.  Additional information and analysis of TST is reported in 
Appendix C.     
3. 4 LINEAR REGRESSION RESULTS  
 Using the factor scores for each case that were generated from each PCA, 
multiple linear regressions were performed to exam associations of physiological, 
cognitive, and mood data with the Disturbance component scores and TST.  Linear 
regressions were also performed on transformed clinician-administered mood 
assessments (HAM-A and HAM-D), blood pressure, and heart rate data. 
 3.4.1 Physiological components. Two multiple linear regressions were 
performed to assess Cardiovascular Risk and Lipid Profile components from the 
Disturbance component and TST.  The baseline data were not included sleep PCA 
components because baseline physiological data were not collected.  These variables did 
were not significantly associated with Cardiovascular Risk, F(2, 19)=2.499, p=.112, 
R
2
=.227 or Lipid Profile, F(2, 19)=01.640, p=.223, R
2
=.162. 
3.4.2 Cognition components. Three multiple linear regressions were performed 
to examine associations of Executive Control (Motor Planning), Vigilance, and Working 
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Memory components with TST and the Disturbance component.  The baseline data were 
included in the TST and Disturbance data.  These variables did not were not significantly 
associated with Executive Control (F(2, 29)=.191, p=.827, R
2
=.014), Vigilance (F(2, 
29)=1.074, p=.356, R
2
=.074), or Working Memory, (F(2, 29)=1.542, p=.232, R
2
=.103).  
There were not enough participants to utilize order effects in an analysis.  The cognitive 
variables on the sleep variables had no impact when the baseline data were covaried from 
the analysis. 
 3.4.3 Mood and Sleepiness components. Two multiple linear regressions were 
performed to assess the association of the Mood (Emotional State) component with TST 
and the Disturbance component.  The baseline data were included in the TST and 
Disturbance data.   These associations approached statistical significance F(2, 59)=2.879, 
p=.064, R
2
=.092.  The Disturbance component added statistically significantly to the 
prediction, p=.022.  See Figure 3.3 for the scatterplot representing the relationship 
between the Disturbance and Mood components.  These variables did not statistically 
significantly Sleepiness (F(2, 59)=.976, p=.383, R
2
=.033). 
3.4.4 Clinician-administered mood assessments. Two multiple linear 
regressions were performed to predict anxiety and depressive symptoms (HAM-A and 
HAM-D, respectively) from TST and the Disturbance component.  The baseline data 
were included in the TST and Disturbance data.  These variables did not statistically 
significantly predict anxiety (F(2, 19)=.071, p=.932, R
2
=.008) or depressive symptoms 
(F(2, 19)=.167, p=.848, R
2
=.019).  
3.4.5 Blood pressure and heart rate. Three multiple linear regressions were 
performed to predict systolic blood pressure, diastolic blood pressure, and heart rate from 
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TST and the Disturbance component.  The baseline data were included in the TST and 
Disturbance data.  These variables statistically significantly predicted systolic blood 
pressure, F(2, 79)=7.404, p=.001, R
2
=.161.  The Disturbance component added 
statistically significantly to the prediction, p=.0004.  See Figure 3.4 for the scatterplot 
representing the relationship between the Disturbance component and the systolic blood 
pressure.  These variables statistically significantly predicted diastolic blood pressure, 
F(2, 79)=4.977, p=.009, R
2
=.114.  TST and the Disturbance component added 
statistically significantly to the prediction, p=.016 and p=.031 (Figures 3.5 and 3.6), 
respectively.  These variables statistically significantly predicted heart rate, F(2, 
79)=3.671, p=.030, R
2
=.087.  TST and the Disturbance component added statistically 
significantly to the prediction, p=.047 and p=.050 (Figures 3.7 and 3.8), respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Time in Bed for each Condition. Time in Bed (TIB), as measured in minutes, 
for each condition.  Blue bar represents condition order of normal sleep (NS) followed by 
sleep extension (SE); green bar represents condition order of SE followed by NS.  Error 
bars represent standard error. 
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Figure 3.2. Time in Bed for each Week. Time in Bed (TIB), as measured in minutes, for 
each Baseline (BL) and week (WK) per condition.  Blue line represents condition order 
of normal sleep (NS) followed by sleep extension (SE); green line represents condition 
order of SE followed by NS.  Error bars represent standard error. 
 
Table 3.1. Factor Loadings for Sleep Measures without Baseline  
Table shows sleep measures and corresponding factor loadings.  Actigraphic data do not 
include baseline data. 
 
Measures Component 1  
(Sleep Disturbance) 
Component 2  
(TST) 
Total Sleep Time .057 .994 
Sleep Efficiency -.872 .315 
Number of Awakenings .906 .197 
Sleep Fragmentation .816 .041 
Wake after Sleep Onset .941 .056 
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Table 3.2. Factor Loadings for Sleep Measures with Baseline 
Table shows sleep measures and corresponding factor loadings, with baseline data 
included. 
 
Measures Component 1  
(Sleep Disturbance) 
Component 2  
(TST) 
Total Sleep Time .053 .985 
Sleep Efficiency -.922 .306 
Number of Awakenings .862 .136 
Sleep Fragmentation .797 .156 
Wake after Sleep Onset .944 .046 
 
Table 3.3. Factor Loadings for Physiological Measures 
 
Table shows physiological measures and corresponding factor loadings. 
 
Measures Component 1 
(Cardiovascular Risk) 
Component 2  
(Lipid Profile) 
C-Reactive Protein .720     .125 
Glucose .895 -.207 
High-Density Lipoprotein -.444 -.434 
Triglycerides .314 .654 
Low-Density Lipoprotein -.273 .923 
 
Table 3.4. Factor Loadings for Mood and Sleepiness Measures 
 
Table shows the depression, anxiety, sleepiness, and fatigue difference scores and 
corresponding factor loadings. 
 
Measures Component 1 (Mood) Component 2 (Sleepiness) 
Sleepiness (ESS) -.123 .892 
Fatigue (MAF)  .183 .661 
Depression (BDI)  .894 -.033 
Anxiety (STAI)  .838 .038 
Note. Epworth Sleepiness Scale (ESS); Multidimensional Assessment of Fatigue (MAF), 
Beck Depression Inventory II (BDI II), State-Trait Anxiety Inventory (STAI).  
 57 
Table 3.5. Factor Loadings for Cognitive Measures 
 
Table shows the cognitive measures and corresponding factor loadings. 
 
Measures Component 1 
(Executive 
Control) 
Component 2 
(Vigilance) 
Component 3 
(Working Memory) 
TMT A Total Time .961 .105 .120 
TMT B Total Time .928 -.099 .008 
Stroop Interference Score .581 .389 -.120 
PVT Log Reaction Time .232 .844 -.114 
PVT Number of Lapses .015 .871 -.031 
Rspan Score -.467 .621 .263 
SB5 BPMT .143 -.052 .889 
SB5 SMT .040 -.045 .830 
Note. Trail Making Test (TMT), Psychomotor Vigilance Task (PVT), Automated 
Reading Span (Rspan), Stanford-Binet 5 (SB5), Block Pattern Memory Task (BPMT), 
Sentence Memory Task (SMT). 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Scatterplot of Mood and Sleep Disturbance Components.  No outliers (±3 
standard deviations from mean) were identified in regression analysis. 
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Figure 3.4. Scatterplot of Disturbance Component and Systolic Blood Pressure.  No 
outliers (±3 standard deviations from mean) were identified in regression analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Scatterplot of Total Sleep Time and Diastolic Blood Pressure.  No outliers 
(±3 standard deviations from mean) were identified in regression analysis. 
 59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Scatterplot of Disturbance Component and Diastolic Blood Pressure.  No 
outliers (±3 standard deviations from mean) were identified in regression analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Scatterplot of Total Sleep Time and Heart Rate.  No outliers (±3 standard 
deviations from mean) were identified in regression analysis. 
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Figure 3.8. Scatterplot of Disturbance Component and Heart Rate.  No outliers (±3 
standard deviations from mean) were identified in regression analysis.
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CHAPTER 4 
DISCUSSION 
The goal of this study was to examine the association of sleep duration with 
multiple outcomes in older adults.  In a randomized controlled trial, healthy, older adults 
were asked to spend 2 extra hours in bed per night during a sleep extension condition.  
Participants also completed a habitual sleep condition.  Physiological, cognitive, and 
mood measures were taken throughout the study.  Epidemiological studies have clearly 
shown negative associations with long sleep duration, including associations with several 
morbidities and increased mortality.  Due to the growing evidence of the harmful effects 
of long sleep duration, it was hypothesized that greater sleep duration would be 
associated with unhealthy levels of physiological measures, decreased mood state, and 
cognitive performance.  Additionally, it was hypothesized that more sleep disturbance 
would be associated with unhealthy levels of these variables. 
As expected, participants were able to spend additional time in bed.  Participants 
spent approximately 70 additional minutes in bed attempting to sleep.  Participants also 
increased their total sleep time approximately 50 minutes compared to their habitual sleep 
time.  Although participants were not able to extend their sleep to the full 2 hours, other 
sleep extension studies have shown significant differences in sleep quality and sleepiness 
in as little as 14 minutes of increased sleep time (Cizza et al., 2014).  These results were 
consistent with our pilot data, in which we found statistically significant increases in total 
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sleep time after asking participants to spend more time in bed attempting to sleep 
(Reynolds et al., 2014). 
Comparisons between treatments were not feasible due to the small sample size.  
Additionally, due to the large number of measures with overlapping variance, principal 
components analysis was a better fit for data reduction as a preliminary analysis.  After 
the measures were reduced, linear regressions were used in order to predict physiological, 
cognitive, and mood measures from the sleep data.  Although the data sample was too 
small to make pre vs. post comparisons, clear patterns emerged when examining the data.  
Computing linear regressions to predict physiological, cognitive, and mood measures was 
more feasible for the study design and smaller sample size.   
Although group comparisons were not feasible, it was clear that the results were 
not consistent with the hypothesis that more sleep duration would be associated with 
worse physiological health and cognitive performance.  Unexpectedly, TST had a more 
positive association with blood pressure and heart rate.  Higher levels of TST were 
associated with decreased diastolic blood pressure and heart rate.  Even though 
epidemiological evidence suggests otherwise, experimental study of sleep extension had 
not yet been conducted in older adults.  It is possible that sleep extension in older adults 
is not harmful, as previously suggested.  One potential explanation is that the older adults 
who participated in the study were not sleeping at their optimal level and had obtained a 
sleep debt.  Three weeks of extended sleep may have relieved that debt and resulted in 
improved physiological health. 
Unexpectedly, TST and sleep disturbances did not predict any associations of 
cardiovascular risk, lipid profile, executive function, vigilance, working memory, 
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sleepiness, or clinician-administered mood assessments.  It is important to note that these 
null results could imply that increased sleep duration may be neither harmful nor helpful 
to certain aspects of physiological, psychological, or emotional health.  It can be posited 
that these null results provide evidence that normal-sleeping older adults without 
significant health conditions, who increase their total sleep time, do not benefit in these 
specific aspects of health.  However, a larger sample size is needed in order to make 
concrete conclusions. 
As expected, sleep disturbances impacted mood and blood pressure.  Sleep 
disturbances had a negative impact on mood, systolic blood pressure, diastolic blood 
pressure, and heart rate.  As sleep became increasingly disturbed, diastolic blood 
pressure, systolic blood pressure, and heart rate increased.  Additionally, higher levels of 
sleep disturbance were associated with changes to a more negative mood.  These results 
are consistent with sleep disturbance studies, including those examining individuals with 
sleep apnea, restless leg syndrome, and other conditions that are associated with 
increased disruption of sleep.  Additionally, as sleep time increased, sleep disturbances 
also increased.  These results are consistent with the literature on sleep extension.  
A major limitation of this study is the small sample size.  The small sample size 
limits the statistical analysis and conclusions that can be made from the data.  However, 
according to Comrey and Lee (1992), a sample size of 200 cases is considered “fair,” 300 
as “good,” and 500 as “very good” for factor analysis.  Since the sleep, cognitive, and 
mood data consisted of at least 300 cases, these were considered “good.”  Due to the 
limited number of cases for the physiological data (100 cases), caution should be made 
regarding conclusions derived from the analysis of this set of data.  Additionally, only 
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four participants were randomized to the sleep extension condition first, which was not 
enough for order comparisons against the six participants who were randomized to the 
habitual sleep condition first.   
Another limitation and interesting observation is the potential order effects.  As 
seen in Figure C.2, participants who were randomized to the sleep extension condition 
first were able to extend their sleep longer than those who were randomized to the 
habitual sleep condition first.  However, it is possible that, with a greater sample size in 
this condition, the data would be more similar to the opposing group.  If there are indeed 
order effects, it may be beneficial to conduct a future study examining these effects.  
Since there have been no other cross-over studies of sleep extension in older adults, 
additional studies are needed to determine if this is the most appropriate design for a 
sleep extension study.  Additionally, future cross-over studies should carefully examine 
the length of the recovery period.  It is also possible that the recovery period of 1 week 
may need to be extended in future studies if evidence is found for carry-over effects.   
The current study is the most comprehensive sleep extension study in older adults 
to date.  Although limited by small sample size, patterns in the data emerged that were 
explained by rest and sleep disturbance components.  This study was the first of its kind 
to use the cross-over research design for sleep extension in older adults, which provided 
interesting information in terms of order effects.  Future randomized controlled trials 
should examine longer duration (i.e. more than 3 weeks) in sleep extension studies in 
order to determine to what extent older adults may or may not benefit from extension of 
sleep duration.
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APPENDIX A – SCREENING DATA 
 
Table A.1. Descriptive Statistics for Screening Data 
Means and standard deviations for screening and demographic data.  
 
Measure  (N=24, 3 Male) 
Age 
      M 65.71 
     SD   5.55 
Body Mass Index 
      M 27.20 
     SD   4.09 
Subjective Total Sleep Time (hours) 
      M     7.14 
     SD     0.78 
Patient Health Questionnaire-9 
      M      1.13 
     SD      1.26 
Beck Scale for Suicide Ideation 
      M      0.00 
     SD      0.00 
Mini Mental State Exam 
      M    28.58 
     SD      1.10 
Expectations Questionnaire 
      M    13.88 
     SD      2.52 
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APPENDIX B – DESCRIPTIVE STATISTICS OF RAW AND TRANSFORMED DATA 
 
Means and standard deviations reported for raw sleep data (Table B.1), 
physiological (Table B.2), blood pressure and heart rate data (Table B.3), mood data 
(Table B.4), and cognition data (Table B.5). 
Table B.1. Descriptive Statistics for Raw Sleep Data 
Means and standard deviations for raw sleep data.  
 
Sleep Measures 
Normal Sleep 
(N=30) Sleep Extension 
   Time in Bed 
       M 484.86 555.06 
     SD   27.82   35.49 
Total Sleep Time 
       M 424.88 475.11 
     SD   28.87   49.72 
Number of Awakenings 
       M   22.49   27.32 
     SD     5.47     4.87 
Sleep Efficiency (%) 
       M    88.30   87.37 
     SD      3.41     2.68 
Sleep Fragmentation (%) 
       M    25.97    29.78 
     SD      5.59      4.68 
Wake after Sleep Onset  
       M    44.53    55.35 
     SD    14.39    11.76 
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Table B.2. Descriptive Statistics for Physiological Data  
Means and standard deviations for raw and transformed physiological data. 
Physiological Measures 
Normal Sleep 
(N=10) Sleep Extension 
C-Reactive Protein (log10) 
       M  0.11  0.06 
     SD  0.39  0.36 
Glucose 
       M 92.70 92.30 
     SD   6.17   6.11 
Triglycerides 
       M 70.40 75.20 
     SD 11.10 17.69 
High-Density Lipoprotein 
       M 74.10 73.30 
     SD 20.72 14.65 
Low-Density Lipoprotein (sqrt) 
       M  9.95  9.97 
     SD  2.19  1.80 
   
   Table B.3. Descriptive Statistics for Blood Pressure and Heart Rate Data. 
Means and standard deviations for raw blood pressure and transformed heart rate data. 
  
  
Blood Pressure and Heart Rate 
Normal Sleep 
(N=30) Sleep Extension 
Systolic 
       M 124.14 123.56 
     SD   15.30   13.59 
Diastolic 
       M 70.68   69.39 
     SD   7.49    7.11 
Heart Rate (sqrt) 
       M   8.34    8.37 
     SD   0.53    0.65 
    
 89 
Table B.4. Descriptive Statistics for Mood and Sleepiness Data 
Means and standard deviations for transformed mood and sleepiness data. 
   Mood Scores Normal Sleep Sleep Extension 
Beck Depression Inventory II 
(n=30) 
       M  0.00 -0.57 
     SD  1.84  1.65 
State-Trait Anxiety Inventory 
(n=30) 
       M  1.70 -0.11 
     SD  6.37  5.10 
Epworth Sleepiness Scale (n=30) 
       M  0.33  0.53 
     SD  2.56  1.83 
Multidimensional Assessment of 
Fatigue (n=30) 
       M  0.69 -0.55 
     SD  4.64  4.31 
Hamilton Anxiety Inventory 
(n=10) 
       M -0.22 -0.60 
     SD   2.00  2.07 
Hamilton Depression Inventory 
(n=10) 
       M  -0.32 -0.50 
     SD   0.94  1.72 
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Table B.5. Descriptive Statistics for Cognitive Data 
Means and standard deviations for raw and transformed cognitive data. 
   
Cognitive Measures 
Normal Sleep 
(N=10) Sleep Extension 
Stroop Interference (log) 
       M   1.52   1.55 
     SD   0.14   0.08 
Trail Making Test A (s) 
       M 34.46 29.51 
     SD 18.98 13.72 
Trail Making Test B (s) 
       M 85.04 74.39 
     SD 63.99 41.54 
Psychomotor Vigilance Test (log) 
      M   2.47   2.47 
     SD   0.07   0.06 
Psychomotor Vigilance Test 
Number of Lapses 
       M   2.30   1.30 
     SD   3.89   3.13 
Automated Reading Span Score 
       M 30.50 36.20 
     SD 21.46 22.04 
Stanford-Binet 5 Block Pattern 
Memory Task 
       M 18.70 18.50 
     SD   2.91   2.76 
Stanford-Binet 5 Sentence Memory 
Task 
       M 20.18 19.60 
     SD   2.15   1.84 
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APPENDIX C – COMPARISONS OF RAW DATA 
 A paired samples t-test revealed that actigraphic TST statistically significantly 
increased from 424.88±24.49 min in the normal sleep condition to 475.11±43.43 min 
during the sleep extension condition, t(9)=-6.327, p<.001.  Figure 1 shows the average 
TST in minutes for each group.  Figure 2 shows the cross-over nature of the study for 
TST for each week of the study.  Additional t-tests of raw data are shown for sleep data 
(Table C.1), physiological data (Table C.2), mood data (Table C.3), and cognitive data 
(Table C.4).  Correlation matrices are shown for the raw sleep data (Table C.5), raw 
physiological data (Table C.6), raw mood and sleepiness data (Table C.7), and raw 
cognitive data (Table C.8).  
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Figure C.1. Total Sleep Time for each Condition. Blue bar represents condition order of 
normal sleep (NS) followed by sleep extension (SE); green bar represents condition order 
of SE followed by NS.  Error bars represent standard error. 
 
 
 
 
 
 
 
 
 
Figure C.2. Total Sleep Time for each Week. Total sleep time, as measured in minutes, 
for each Baseline (BL) and week (WK) per condition.  Blue line represents condition 
order of normal sleep (NS) followed by sleep extension (SE); green line represents 
condition order of SE followed by NS.  Error bars represent standard error. 
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Table C.1. Raw Sleep Data Comparisons 
T-tests for raw sleep measurements. 
Note. Time in bed (TIB), total sleep time (TST), wake after sleep onset (WASO) 
Table C.3. Raw Blood Pressure and Heart Rate Data Comparisons 
T-tests for raw blood pressure and heart rate measurements. 
Blood Pressure and Heart Rate Measures 
Blood Pressure 
and Heart Rate 
Measures t Df P-Value M SE 
Systolic  0.156 58 0.876  0.583 3.736 
Diastolic  0.681 58 0.499  1.283 1.885 
Heart Rate -0.159 58 0.874 -0.024 0.152 
 
 
 
 
Sleep Measures 
Sleep Measures T df P-Value M SE 
TIB   -8.527 58 0.000 -70.199   8.23283 
TST   -4.786 58 0.000   -50.2357 10.49674 
Awakenings   -3.614 58 0.001      -4.83167   1.33702 
Sleep Efficiency    1.164 58 0.249       0.92133   0.79154 
Sleep Fragmentation -2.86 58 0.006      -3.80467   1.33031 
WASO -3.19 58 0.002  -10.8217   3.39237 
Table C.2. Raw Physiological Data Comparisons 
T-tests for raw physiological measurements. 
Physiological Measures 
Physiological 
Measures t Df P-Value M SE 
CRP  0.276 18 0.786  0.047 0.169 
Glucose  0.146 18 0.886  0.400 2.745 
Trig -0.727 18 0.477 -4.800 6.603 
HDL 0.100 18 0.922  0.800 8.024 
LDL -0.026 18 0.979 -0.024 0.896 
Note. C-reactive protein (CRP), high-density lipoprotein (HDL), low-density lipoprotein 
(LDL). 
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Table C.4. Raw Mood Data Comparisons  
 
T-tests for raw mood measurements. 
Mood Difference Scores 
Mood 
Difference 
Scores t df P-Value M SE 
BDI  1.255 58 0.215  0.567 0.452 
STAI  1.212 58 0.230  1.807 1.490 
ESS -0.348 58 0.729 -0.200 0.575 
MAF  1.075 58 0.287  1.243 1.157 
HAMA  0.418 18 0.681  0.380 0.909 
HAMD  0.291 18 0.775  0.180 0.619 
Note. Beck Depression Inventory II (BDI), State-Trait Anxiety Inventory (STAI), 
Epworth Sleepiness Scale (ESS), Multidimensional Assessment of Fatigue (MAF), 
Hamilton Anxiety Inventory (HAM-A), Hamilton Depression Inventory (HAM-D). 
 
Table C.5. Raw and Transformed Cognitive Data Comparisons 
 
T-tests for raw and transformed cognitive measurements. 
Cognitive Measures 
Cognitive Measures T df P-Value M SE 
      Stroop Interference Score (log)   -0.741 18 0.468  -0.037   0.050 
Trail Making Test A    0.669 18 0.512   4.955   7.405 
Trail Making Test B    0.442 18 0.664 10.652 24.124 
PVT Mean Responses (log) -0.02 18 0.984  -0.001   0.028 
PVT Number of Lapses    0.634 18 0.534   1.000   1.578 
Automated Reading Span Score  -0.586 18 0.565  -5.700   9.729 
SB5 BPMT   0.158 18 0.876   0.200   1.268 
SB5 SMT   0.648 18 0.525   0.580   0.895 
Note.  Psychomotor vigilance test (PVT), Stanford-Binet 5 (SB5), Block Pattern Memory 
Task (BPMT), Sentence Memory Task (SMT).  
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Table C.6. Raw Sleep Data Correlation Matrix 
Table shows correlation matrix of raw sleep data. 
 
 TST Sleep 
Efficiency 
Number of 
Awakenings 
Sleep 
Fragmentation 
WASO 
TST     
Sleep Efficiency  .170    
Number of 
Awakenings 
 .191 -.688**   
Sleep 
Fragmentation 
 .186 -.628**     .589**  
WASO  .160 -.863**  .788**  .666** 
Note. Total Sleep Time (TST), Wake after Sleep Onset (WASO); *, p<.05; **, p<.01 
 
Table C.7. Raw Physiological Data Correlation Matrix 
 
Table shows correlation matrix of raw physiological data. 
 CRP Glucose Triglycerides HDL LDL 
CRP      
Glucose .277     
Triglycerides .234  .253    
HDL  -.461* -.297 -.321   
LDL -.032 -.136  .373 -.196  
Note. C-reactive protein (CRP), high-density lipoprotein (HDL), low-density lipoprotein 
(LDL); *, p<.05. 
 
Table C.8. Raw Mood and Sleepiness Data Correlation Matrix 
 
Table shows correlation matrix of raw mood and sleepiness data. 
 ESS MAF BDI STAI Daily Mood 
ESS      
MAF      .615**     
BDI      .298**   .371**    
STAI    .236*    .375**  .586**   
Daily Mood -.132 -.100 -.174 -.218  
Note. Epworth Sleepiness Scale (ESS); Multidimensional Assessment of Fatigue (MAF), 
Beck Depression Inventory II (BDI II), State-Trait Anxiety Inventory (STAI); *, p<.05; 
**, p<.01 
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Table C.9. Raw Cognitive Data Correlation Matrix 
 
Table shows correlation matrix of raw cognitive data. 
 TMT A TMT 
B 
Stroop Int. PVT 
Log 
RT 
PVT 
Lapses 
Rspan SB5 
BPMT 
SB5 
SMT 
TMT A          
TMT B      .722**        
Stroop Int.     .578**   .647**       
PVT Log 
RT 
  .463* .344    
.477** 
     
PVT Lapses .224 .110   .328     
.730** 
    
Rspan  -.226 -.243 -.064 .253  .261    
SB5 BPMT .123 -.199   -.040 .049  .133 .290   
SB5 SMT -.128 -.327 -.431* -.041 -.086 .154 .345  
Note. Trail Making Test (TMT), Stroop Int. (Stroop Interference), Psychomotor 
Vigilance Task (PVT), reaction time (RT), Automated Reading Span (Rspan), Stanford-
Binet 5 (SB5), Block Pattern Memory Task (BPMT), Sentence Memory Task (SMT); *, 
p<.05; **, p<.01 
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APPENDIX D – HISTOGRAMS OF RAW AND TRANSFORMED DATA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a.   b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
d.  e.
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 f.  
Figure D.1. Histograms of Raw Sleep Data. Histograms include time in bed (a), total 
sleep time (b), sleep efficiency (c), sleep fragmentation (d), and number of awakenings 
(f) raw data. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
a.   b. 
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 c.  d.  
Figure D.2. Histograms of Raw and Transformed Physiological Data. C-reactive protein 
(CRP, a) log transformed and raw glucose (b), triglycerides (c), and high-density 
lipoproteins (HDL, d) data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a.  b. 
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 c.  
 
Figure D.3. Histograms of Blood Pressure and Heart Rate Data. Histograms of raw 
systolic (a) and diastolic (b) blood pressure and square root transformed heart rate data 
(c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a.  b. 
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 a.  b. 
Figure D.4. Histograms of Transformed Mood Data. Mood and fatigue data include Beck 
Depression Inventory II (a), Hamilton Anxiety Rating Scale (HAM-A, b), Hamilton 
Depression Rating Scale (HAM-D, c), Multidimensional Assessment of Fatigue (d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a.  b. 
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 c.  d. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 e.  f. 
 
 
 
 
 
 
 103 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 g.  
 
Figure D.5. Histograms of Cognitive Data. Histograms for Trail Making Test A (TMT-A, 
a), Trail Making Test B (TMT-B, b), log transformed psychomotor vigilance test (PVT, 
c), PVT number of lapses (d), Automated Operating Reading Span (Rspan, e), Stanford-
Binet 5 (SB5) Verbal (V) Raw Score (f), SB5 Nonverbal (NV) Raw Score (g) data. 
 
